Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | AARS1 CL E G H | 16 | 20 | OMIM:619661 | LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2 | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | AARS1 CL E G H | 16 | 20 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | AARS2 CL E G H | 57505 | 21022 | OMIM:615889 | Leukoencephalopathy, progressive, with ovarian failure | | | | 143 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | AASS CL E G H | 10157 | 17366 | ORPHA:3124 | Saccharopinuria | HP:0040283 - Occasional | | | 15 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ABCA7 CL E G H | 10347 | 37 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ABCD1 CL E G H | 215 | 61 | OMIM:300100 | Adrenoleukodystrophy | . | | | 135 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ABCD1 CL E G H | 215 | 61 | ORPHA:139396 | X-linked cerebral adrenoleukodystrophy | HP:0040281 - Very frequent | | | 135 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ACTB CL E G H | 60 | 132 | ORPHA:79107 | Developmental malformations-deafness-dystonia syndrome | HP:0040281 - Very frequent | | | 72 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ACTL6B CL E G H | 51412 | 160 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ADA2 CL E G H | 51816 | 1839 | ORPHA:820 | Sneddon syndrome | HP:0040282 - Frequent | | | 22 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ADA2 CL E G H | 51816 | 1839 | OMIM:182410 | Sneddon syndrome | . | | | 22 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ADH1C CL E G H | 126 | 251 | OMIM:168600 | Parkinson disease, late-onset | | | | 4 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ALDH18A1 CL E G H | 5832 | 9722 | ORPHA:447753 | Autosomal dominant spastic paraplegia type 9A | | | | 89 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ALDH18A1 CL E G H | 5832 | 9722 | ORPHA:447757 | Autosomal dominant spastic paraplegia type 9B | | | | 89 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | AMACR CL E G H | 23600 | 451 | ORPHA:79095 | Congenital bile acid synthesis defect type 4 | | | | 44 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | AP3B2 CL E G H | 8120 | 567 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 7 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | AP5Z1 CL E G H | 9907 | 22197 | OMIM:613647 | Spastic paraplegia 48, autosomal recessive | . | | | 165 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APOE CL E G H | 348 | 613 | OMIM:104310 | Alzheimer disease 2 | | | | 39 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APOE CL E G H | 348 | 613 | OMIM:607822 | Alzheimer disease 3 | | | | 39 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APOE CL E G H | 348 | 613 | OMIM:606889 | Alzheimer disease 4 | | | | 39 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APOL2 CL E G H | 23780 | 619 | OMIM:181500 | SCHIZOPHRENIA | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APOL4 CL E G H | 80832 | 14867 | OMIM:181500 | SCHIZOPHRENIA | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APP CL E G H | 351 | 620 | ORPHA:100006 | ABeta amyloidosis, Dutch type | HP:0040281 - Very frequent | | | 74 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APP CL E G H | 351 | 620 | ORPHA:324708 | ABeta amyloidosis, Iowa type | | | | 74 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APP CL E G H | 351 | 620 | ORPHA:324713 | ABeta amyloidosis, Italian type | HP:0040282 - Frequent | | | 74 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APP CL E G H | 351 | 620 | ORPHA:324703 | ABetaL34V amyloidosis | | | | 74 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APP CL E G H | 351 | 620 | OMIM:104300 | Alzheimer disease | | | | 74 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APP CL E G H | 351 | 620 | OMIM:605714 | Cerebral amyloid angiopathy, APP-related | | | | 74 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APP CL E G H | 351 | 620 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 74 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | APTX CL E G H | 54840 | 15984 | OMIM:208920 | Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | HP:0040283 - Occasional | | | 61 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ARSA CL E G H | 410 | 713 | OMIM:250100 | Metachromatic leukodystrophy | . | | | 253 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 253 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ARSA CL E G H | 410 | 713 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 253 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ARV1 CL E G H | 64801 | 29561 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ASAH1 CL E G H | 427 | 735 | OMIM:159950 | Spinal muscular atrophy with progressive myoclonic epilepsy | | | | 78 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ASAH1 CL E G H | 427 | 735 | ORPHA:2590 | Spinal muscular atrophy-progressive myoclonic epilepsy syndrome | HP:0040283 - Occasional | | | 78 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATN1 CL E G H | 1822 | 3033 | ORPHA:101 | Dentatorubral pallidoluysian atrophy | | | | 16 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATN1 CL E G H | 1822 | 3033 | OMIM:125370 | Dentatorubral-Pallidoluysian atrophy naito-oyanagi disease haw river syndrome ataxia, chorea, seizures, and dementia | | | | 16 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP13A2 CL E G H | 23400 | 30213 | ORPHA:513436 | Autosomal recessive spastic paraplegia type 78 | | | | 100 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP13A2 CL E G H | 23400 | 30213 | OMIM:606693 | Kufor-Rakeb syndrome | | | | 100 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP13A2 CL E G H | 23400 | 30213 | ORPHA:306674 | Kufor-Rakeb syndrome | HP:0040283 - Occasional | | | 100 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP13A2 CL E G H | 23400 | 30213 | OMIM:617225 | SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78 | | | | 100 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP1A2 CL E G H | 477 | 800 | ORPHA:2131 | Alternating hemiplegia of childhood | | | | 239 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP1A2 CL E G H | 477 | 800 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 239 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP1A3 CL E G H | 478 | 801 | ORPHA:2131 | Alternating hemiplegia of childhood | | | | 150 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP1A3 CL E G H | 478 | 801 | OMIM:614820 | Alternating hemiplegia of childhood 2 | . | | | 150 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP1A3 CL E G H | 478 | 801 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 150 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP6 CL E G H | 4508 | 7414 | ORPHA:644 | NARP syndrome | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP6 CL E G H | 4508 | 7414 | OMIM:551500 | Neuropathy, ataxia, and retinitis pigmentosa | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP6V1A CL E G H | 523 | 851 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP6V1A CL E G H | 523 | 851 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP6V1E1 CL E G H | 529 | 857 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | | | | 315 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATXN10 CL E G H | 25814 | 10549 | OMIM:603516 | Spinocerebellar ataxia 10 | | | | 9 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATXN2 CL E G H | 6311 | 10555 | OMIM:168600 | Parkinson disease, late-onset | | | | 11 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATXN2 CL E G H | 6311 | 10555 | OMIM:183090 | Spinocerebellar ataxia 2 | | | | 11 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATXN2 CL E G H | 6311 | 10555 | ORPHA:98756 | Spinocerebellar ataxia type 2 | | | | 11 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATXN3 CL E G H | 4287 | 7106 | OMIM:109150 | Machado-Joseph disease | | | | 14 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATXN7 CL E G H | 6314 | 10560 | OMIM:164500 | Spinocerebellar ataxia 7 opca III opca with retinal degeneration opca with macular degeneration and external ophthalmoplegia autosomal dominant cerebellar ataxia, type II adca, type II | | | | 8 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATXN7 CL E G H | 6314 | 10560 | ORPHA:94147 | Spinocerebellar ataxia type 7 | HP:0040282 - Frequent | | | 8 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ATXN8OS CL E G H | 6315 | 10561 | OMIM:168600 | Parkinson disease, late-onset | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | AUH CL E G H | 549 | 890 | OMIM:250950 | 3-methylglutaconic aciduria, type I | | | | 49 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | BSCL2 CL E G H | 26580 | 15832 | OMIM:615924 | Encephalopathy, progressive, with or without lipodystrophy | . | | | 105 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:363400 | Severe neurodegenerative syndrome with lipodystrophy | | | | 105 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | C19ORF12 CL E G H | 83636 | 25443 | ORPHA:289560 | Mitochondrial membrane protein-associated neurodegeneration | HP:0040281 - Very frequent | | | 114 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | C19ORF12 CL E G H | 83636 | 25443 | OMIM:614298 | Neurodegeneration with brain iron accumulation 4 | . | | | 114 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | C9ORF72 CL E G H | 203228 | 28337 | OMIM:105550 | Amyotrophic lateral sclerosis and/or frontotemporal dementia 1 | | | | 56 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 56 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 56 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 56 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:100069 | Semantic dementia | | | | 56 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CACNA1A CL E G H | 773 | 1388 | ORPHA:2131 | Alternating hemiplegia of childhood | | | | 449 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CACNA1A CL E G H | 773 | 1388 | ORPHA:2382 | Lennox-Gastaut syndrome | HP:0040282 - Frequent | | | 449 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CACNA1A CL E G H | 773 | 1388 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 449 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CACNA1B CL E G H | 774 | 1389 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 5 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CACNA2D1 CL E G H | 781 | 1399 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 59 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CARS2 CL E G H | 79587 | 25695 | OMIM:616672 | Combined oxidative phosphorylation deficiency 27 | | | | 35 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CCNF CL E G H | 899 | 1591 | OMIM:619141 | FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 5; FTDALS5 | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CDK19 CL E G H | 23097 | 19338 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CELF2 CL E G H | 10659 | 2550 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CERS1 CL E G H | 10715 | 14253 | OMIM:616230 | Epilepsy, progressive myoclonic, 8 | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CFAP43 CL E G H | 80217 | 26684 | OMIM:236690 | Hydrocephalus, normal pressure, 1 | | | | 6 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CHCHD10 CL E G H | 400916 | 15559 | OMIM:615911 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 | | | | 11 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CHCHD10 CL E G H | 400916 | 15559 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 11 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CHD2 CL E G H | 1106 | 1917 | ORPHA:2382 | Lennox-Gastaut syndrome | HP:0040282 - Frequent | | | 227 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CHI3L1 CL E G H | 1116 | 1932 | OMIM:181500 | SCHIZOPHRENIA | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CHMP2B CL E G H | 25978 | 24537 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 42 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CHMP2B CL E G H | 25978 | 24537 | OMIM:600795 | Frontotemporal dementia and/or amytrophic lateral sclerosis 7 | | | | 42 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CHMP2B CL E G H | 25978 | 24537 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 42 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CHMP2B CL E G H | 25978 | 24537 | ORPHA:100069 | Semantic dementia | | | | 42 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CISD2 CL E G H | 493856 | 24212 | ORPHA:3463 | Wolfram syndrome | | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CLN3 CL E G H | 1201 | 2074 | OMIM:204200 | Ceroid lipofuscinosis, neuronal, 3 | | | | 216 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CLN3 CL E G H | 1201 | 2074 | ORPHA:228346 | CLN3 disease | | | | 216 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CLN5 CL E G H | 1203 | 2076 | OMIM:256731 | Ceroid lipofuscinosis, neuronal, 5 | | | | 141 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CLN5 CL E G H | 1203 | 2076 | ORPHA:228360 | CLN5 disease | HP:0040282 - Frequent | | | 141 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CLN6 CL E G H | 54982 | 2077 | OMIM:204300 | Ceroid lipofuscinosis, neuronal, 4A, autosomal recessive | | | | 143 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CLN6 CL E G H | 54982 | 2077 | OMIM:601780 | Ceroid lipofuscinosis, neuronal, 6 | | | | 143 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CLN8 CL E G H | 2055 | 2079 | OMIM:610003 | Ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant | . | | | 111 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CLN8 CL E G H | 2055 | 2079 | ORPHA:1947 | Progressive epilepsy-intellectual disability syndrome, Finnish type | | | | 111 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CLTC CL E G H | 1213 | 2092 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CNKSR2 CL E G H | 22866 | 19701 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 18 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CNTNAP2 CL E G H | 26047 | 13830 | ORPHA:163681 | CNTNAP2-related developmental and epileptic encephalopathy | | | | 518 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CNTNAP2 CL E G H | 26047 | 13830 | OMIM:610042 | Pitt-Hopkins-Like syndrome 1 | | | | 518 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COASY CL E G H | 80347 | 29932 | OMIM:615643 | Neurodegeneration with brain iron accumulation 6 | . | | | 16 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COG2 CL E G H | 22796 | 6546 | ORPHA:435934 | COG2-CDG | | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COL4A1 CL E G H | 1282 | 2202 | OMIM:618564 | MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL | | | | 193 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COMT CL E G H | 1312 | 2228 | OMIM:181500 | SCHIZOPHRENIA | | | | 6 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COX1 CL E G H | 4512 | 7419 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COX2 CL E G H | 4513 | 7421 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COX3 CL E G H | 4514 | 7422 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | COX6B1 CL E G H | 1340 | 2280 | OMIM:619051 | MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7; MC4DN7 | | | | 10 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CP CL E G H | 1356 | 2295 | OMIM:604290 | ACERULOPLASMINEMIA | | | | 115 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353281 | Rubinstein-Taybi syndrome due to 16p13.3 microdeletion | | | | 291 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353277 | Rubinstein-Taybi syndrome due to CREBBP mutations | | | | 291 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CSF1R CL E G H | 1436 | 2433 | OMIM:618476 | Brain abnormalities, neurodegeneration, and dysosteosclerosis | . | | | 149 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CSF1R CL E G H | 1436 | 2433 | OMIM:221820 | Leukoencephalopathy, diffuse hereditary, with spheroids | . | | | 149 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CST3 CL E G H | 1471 | 2475 | OMIM:105150 | Amyloidosis VI | | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CSTB CL E G H | 1476 | 2482 | OMIM:254800 | Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg) | | | | 51 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CSTB CL E G H | 1476 | 2482 | ORPHA:308 | Progressive myoclonic epilepsy type 1 | | | | 51 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CTC1 CL E G H | 80169 | 26169 | OMIM:612199 | Cerebroretinal microangiopathy with calcifications and cysts | . | | | 160 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | | | | 178 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CTSD CL E G H | 1509 | 2529 | OMIM:610127 | Ceroid lipofuscinosis, neuronal, 10 | . | | | 159 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CTSF CL E G H | 8722 | 2531 | OMIM:615362 | Ceroid lipofuscinosis, neuronal, 13 | . | | | 20 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CUBN CL E G H | 8029 | 2548 | OMIM:261100 | Megaloblastic anemia 1 | | | | 273 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CUX2 CL E G H | 23316 | 19347 | ORPHA:2382 | Lennox-Gastaut syndrome | HP:0040282 - Frequent | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CYC1 CL E G H | 1537 | 2579 | OMIM:615453 | Mitochondrial complex III deficiency, nuclear type 6 | | | | 12 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CYFIP2 CL E G H | 26999 | 13760 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CYLD CL E G H | 1540 | 2584 | OMIM:619132 | FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 8; FTDALS8 | | | | 126 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CYP27A1 CL E G H | 1593 | 2605 | ORPHA:909 | Cerebrotendinous xanthomatosis | | | | 114 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CYP27A1 CL E G H | 1593 | 2605 | OMIM:213700 | Cerebrotendinous xanthomatosis | | | | 114 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | CYTB CL E G H | 4519 | 7427 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DALRD3 CL E G H | 55152 | 25536 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DAOA CL E G H | 267012 | 21191 | OMIM:181500 | SCHIZOPHRENIA | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DARS2 CL E G H | 55157 | 25538 | ORPHA:137898 | Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome | HP:0040283 - Occasional | | | 60 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DCAF17 CL E G H | 80067 | 25784 | ORPHA:3464 | Woodhouse-Sakati syndrome | HP:0040281 - Very frequent | | | 87 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DCTN1 CL E G H | 1639 | 2711 | OMIM:168605 | Perry syndrome | | | | 86 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DCTN1 CL E G H | 1639 | 2711 | ORPHA:178509 | Perry syndrome | | | | 86 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DGUOK CL E G H | 1716 | 2858 | ORPHA:329314 | Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency | | | | 57 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DHDDS CL E G H | 79947 | 20603 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 47 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DISC2 CL E G H | 27184 | 2889 | OMIM:181500 | SCHIZOPHRENIA | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DLAT CL E G H | 1737 | 2896 | ORPHA:79244 | Pyruvate dehydrogenase E2 deficiency | | | | 82 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DNAJC13 CL E G H | 23317 | 30343 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040283 - Occasional | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DNAJC5 CL E G H | 80331 | 16235 | OMIM:162350 | Ceroid lipofuscinosis, neuronal, 4B, autosomal dominant | | | | 155 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DNAJC6 CL E G H | 9829 | 15469 | ORPHA:2828 | Young-onset Parkinson disease | | | | 6 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DNM1 CL E G H | 1759 | 2972 | ORPHA:2382 | Lennox-Gastaut syndrome | HP:0040282 - Frequent | | | 72 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DNM1 CL E G H | 1759 | 2972 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 72 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DNM1L CL E G H | 10059 | 2973 | ORPHA:98673 | Autosomal dominant optic atrophy, classic form | | | | 94 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DNMT1 CL E G H | 1786 | 2976 | ORPHA:314404 | Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome | HP:0040283 - Occasional | | | 145 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DNMT1 CL E G H | 1786 | 2976 | OMIM:604121 | Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant | | | | 145 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DNMT1 CL E G H | 1786 | 2976 | OMIM:614116 | Neuropathy, hereditary sensory, type IE | | | | 145 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | DRD3 CL E G H | 1814 | 3024 | OMIM:181500 | SCHIZOPHRENIA | | | | 21 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | EEF1A2 CL E G H | 1917 | 3192 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 60 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | EIF4G1 CL E G H | 1981 | 3296 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040283 - Occasional | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | EP300 CL E G H | 2033 | 3373 | ORPHA:353284 | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | | | | 250 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | EPM2A CL E G H | 7957 | 3413 | ORPHA:501 | Lafora disease | HP:0040282 - Frequent | | | 83 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | EPM2A CL E G H | 7957 | 3413 | OMIM:254780 | Myoclonic epilepsy of lafora | | | | 83 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ERCC2 CL E G H | 2068 | 3434 | OMIM:278730 | Xeroderma pigmentosum, complementation group D | . | | | 106 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ERCC4 CL E G H | 2072 | 3436 | OMIM:278760 | Xeroderma pigmentosum, complementation group F | | | | 158 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:214150 | Cerebrooculofacioskeletal syndrome 1 | | | | 199 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ERCC6 CL E G H | 2074 | 3438 | ORPHA:90324 | Cockayne syndrome type 3 | | | | 199 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ERCC6 CL E G H | 2074 | 3438 | OMIM:278800 | De Sanctis-Cacchione syndrome | . | | | 199 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ERCC8 CL E G H | 1161 | 3439 | OMIM:216400 | Cockayne syndrome A | | | | 55 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ERCC8 CL E G H | 1161 | 3439 | ORPHA:90324 | Cockayne syndrome type 3 | | | | 55 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FA2H CL E G H | 79152 | 21197 | ORPHA:171629 | Autosomal recessive spastic paraplegia type 35 | HP:0040282 - Frequent | | | 76 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FA2H CL E G H | 79152 | 21197 | ORPHA:329308 | Fatty acid hydroxylase-associated neurodegeneration | HP:0040281 - Very frequent | | | 76 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FA2H CL E G H | 79152 | 21197 | OMIM:612319 | Spastic paraplegia 35, autosomal recessive | . | | | 76 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FAR1 CL E G H | 84188 | 26222 | ORPHA:447753 | Autosomal dominant spastic paraplegia type 9A | | | | 7 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FBXO7 CL E G H | 25793 | 13586 | ORPHA:171695 | Parkinsonian-pyramidal syndrome | | | | 36 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FGF12 CL E G H | 2257 | 3668 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FGF13 CL E G H | 2258 | 3670 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FMR1 CL E G H | 2332 | 3775 | OMIM:300623 | Fragile X tremor/ataxia syndrome | | | | 30 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FMR1 CL E G H | 2332 | 3775 | ORPHA:93256 | Fragile X-associated tremor/ataxia syndrome | | | | 30 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FRRS1L CL E G H | 23732 | 1362 | ORPHA:725 | Continuous spikes and waves during sleep | | | | 4 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FTL CL E G H | 2512 | 3999 | OMIM:606159 | Neurodegeneration with brain iron accumulation 3 | | | | 33 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FTL CL E G H | 2512 | 3999 | ORPHA:157846 | Neuroferritinopathy | | | | 33 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FUS CL E G H | 2521 | 4010 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 105 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | FZR1 CL E G H | 51343 | 24824 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GABBR2 CL E G H | 9568 | 4507 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 5 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GABRA2 CL E G H | 2555 | 4076 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 4 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GABRA5 CL E G H | 2558 | 4079 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GABRB2 CL E G H | 2561 | 4082 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 44 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GABRB3 CL E G H | 2562 | 4083 | ORPHA:2382 | Lennox-Gastaut syndrome | HP:0040282 - Frequent | | | 57 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GABRG2 CL E G H | 2566 | 4087 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 139 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GALC CL E G H | 2581 | 4115 | ORPHA:206448 | Adult Krabbe disease | HP:0040283 - Occasional | | | 160 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GALC CL E G H | 2581 | 4115 | ORPHA:206436 | Infantile Krabbe disease | HP:0040281 - Very frequent | | | 160 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GALC CL E G H | 2581 | 4115 | OMIM:245200 | Krabbe disease | | | | 160 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GALC CL E G H | 2581 | 4115 | ORPHA:206443 | Late-infantile/juvenile Krabbe disease | HP:0040282 - Frequent | | | 160 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GALK1 CL E G H | 2584 | 4118 | ORPHA:79237 | Galactokinase deficiency | | | | 23 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GALT CL E G H | 2592 | 4135 | ORPHA:79239 | Classic galactosemia | HP:0040282 - Frequent | | | 351 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBA1 CL E G H | 2629 | 4177 | OMIM:127750 | Dementia, lewy body | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBA1 CL E G H | 2629 | 4177 | ORPHA:77261 | Gaucher disease type 3 | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBA1 CL E G H | 2629 | 4177 | OMIM:230900 | Gaucher disease, type II | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBA1 CL E G H | 2629 | 4177 | OMIM:231000 | Gaucher disease, type III | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBA1 CL E G H | 2629 | 4177 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBA1 CL E G H | 2629 | 4177 | OMIM:168600 | Parkinson disease, late-onset | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBA2 CL E G H | 57704 | 18986 | ORPHA:320391 | Autosomal recessive spastic paraplegia type 46 | | | | 30 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBA2 CL E G H | 57704 | 18986 | OMIM:614409 | Spastic paraplegia 46, autosomal recessive | . | | | 30 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GBE1 CL E G H | 2632 | 4180 | ORPHA:206583 | Adult polyglucosan body disease | | | | 86 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GCDH CL E G H | 2639 | 4189 | ORPHA:25 | Glutaryl-CoA dehydrogenase deficiency | | | | 115 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GCH1 CL E G H | 2643 | 4193 | OMIM:233910 | Hyperphenylalaninemia, BH4-deficient, B | | | | 86 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GDAP2 CL E G H | 54834 | 18010 | OMIM:618369 | Spinocerebellar ataxia, autosomal recessive 27 | . | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GIGYF2 CL E G H | 26058 | 11960 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040283 - Occasional | | | 8 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GLB1 CL E G H | 2720 | 4298 | OMIM:230600 | Gm1-gangliosidosis, type II | | | | 120 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GLUD2 CL E G H | 2747 | 4336 | OMIM:168600 | Parkinson disease, late-onset | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GM2A CL E G H | 2760 | 4367 | OMIM:272750 | Gm2-Gangliosidosis, ab variant | | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GNAS CL E G H | 2778 | 4392 | OMIM:219080 | ACTH-independent macronodular adrenal hyperplasia | . | | | 101 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GRIN2A CL E G H | 2903 | 4585 | ORPHA:725 | Continuous spikes and waves during sleep | | | | 434 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GRIN2A CL E G H | 2903 | 4585 | ORPHA:98818 | Landau-Kleffner syndrome | | | | 434 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GRIN2D CL E G H | 2906 | 4588 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GRN CL E G H | 2896 | 4601 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 126 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GRN CL E G H | 2896 | 4601 | OMIM:614706 | Ceroid lipofuscinosis, neuronal, 11 | HP:0040283 - Occasional | | | 126 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GRN CL E G H | 2896 | 4601 | OMIM:607485 | Frontotemporal lobar degeneration with TDP43 inclusions | | | | 126 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GRN CL E G H | 2896 | 4601 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 126 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | GRN CL E G H | 2896 | 4601 | ORPHA:100069 | Semantic dementia | | | | 126 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HCN1 CL E G H | 348980 | 4845 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 54 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HEPACAM CL E G H | 220296 | 26361 | OMIM:613925 | Megalencephalic leukoencephalopathy with subcortical cysts 2A | . | | | 82 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HEXB CL E G H | 3074 | 4879 | OMIM:268800 | Sandhoff disease | | | | 80 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HEXB CL E G H | 3074 | 4879 | ORPHA:309169 | Sandhoff disease, adult form | | | | 80 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HFE CL E G H | 3077 | 4886 | OMIM:104300 | Alzheimer disease | | | | 38 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HGSNAT CL E G H | 138050 | 26527 | OMIM:252930 | Mucopolysaccharidosis type IIIC | | | | 86 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HIBCH CL E G H | 26275 | 4908 | ORPHA:88639 | Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency | | | | 32 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HMBS CL E G H | 3145 | 4982 | ORPHA:79276 | Acute intermittent porphyria | HP:0040282 - Frequent | | | 81 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HNF4A CL E G H | 3172 | 5024 | ORPHA:263455 | Hyperinsulinism due to HNF4A deficiency | | | | 138 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HNRNPA1 CL E G H | 3178 | 5031 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | | | | 31 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HNRNPA2B1 CL E G H | 3181 | 5033 | OMIM:615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | | | | 5 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HNRNPA2B1 CL E G H | 3181 | 5033 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | | | | 5 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HSD17B10 CL E G H | 3028 | 4800 | OMIM:300438 | HSD10 mitochondrial disease | | | | 19 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HTR2A CL E G H | 3356 | 5293 | OMIM:181500 | SCHIZOPHRENIA | | | | 4 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HTRA1 CL E G H | 5654 | 9476 | OMIM:600142 | Autosomal recessive cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) | | | | 34 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HTRA1 CL E G H | 5654 | 9476 | OMIM:616779 | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | | | | 34 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HTRA1 CL E G H | 5654 | 9476 | ORPHA:199354 | Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy | | | | 34 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HTRA2 CL E G H | 27429 | 14348 | ORPHA:2828 | Young-onset Parkinson disease | | | | 39 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HTT CL E G H | 3064 | 4851 | ORPHA:399 | Huntington disease | HP:0040281 - Very frequent | | | 12 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HTT CL E G H | 3064 | 4851 | OMIM:143100 | Huntington disease | | | | 12 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | HTT CL E G H | 3064 | 4851 | ORPHA:248111 | Juvenile Huntington disease | | | | 12 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | IDS CL E G H | 3423 | 5389 | ORPHA:217093 | Mucopolysaccharidosis type 2, attenuated form | HP:0040284 - Very rare | | | 86 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | IDS CL E G H | 3423 | 5389 | ORPHA:217085 | Mucopolysaccharidosis type 2, severe form | HP:0040282 - Frequent | | | 86 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | IDUA CL E G H | 3425 | 5391 | OMIM:607014 | Hurler syndrome | | | | 115 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | IRF6 CL E G H | 3664 | 6121 | OMIM:119500 | Popliteal pterygium syndrome | | | | 99 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ITM2B CL E G H | 9445 | 6174 | OMIM:176500 | Cerebral amyloid angiopathy, itm2b-related, 1 | | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ITM2B CL E G H | 9445 | 6174 | OMIM:117300 | Dementia, familial danish | | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | JAM2 CL E G H | 58494 | 14686 | OMIM:618824 | BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE; IBGC8 | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | JPH3 CL E G H | 57338 | 14203 | OMIM:606438 | Huntington disease-like 2 | | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | JPH3 CL E G H | 57338 | 14203 | ORPHA:98934 | Huntington disease-like 2 | | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | KARS1 CL E G H | 3735 | 6215 | OMIM:619196 | DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | KCNA2 CL E G H | 3737 | 6220 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 13 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | KCNB1 CL E G H | 3745 | 6231 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | KCNC1 CL E G H | 3746 | 6233 | OMIM:616187 | Epilepsy, progressive myoclonic 7 | HP:0040283 - Occasional | | | 6 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | KCTD7 CL E G H | 154881 | 21957 | ORPHA:263516 | Progressive myoclonic epilepsy type 3 | | | | 106 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | KMT2A CL E G H | 4297 | 7132 | ORPHA:319182 | Wiedemann-Steiner syndrome | | | | 91 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | L1CAM CL E G H | 3897 | 6470 | ORPHA:306617 | X-linked complicated spastic paraplegia type 1 | HP:0040283 - Occasional | | | 134 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | LIG3 CL E G H | 3980 | 6600 | OMIM:619780 | MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MNGIE TYPE); MTDPS20 | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | LIG3 CL E G H | 3980 | 6600 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | LMNB1 CL E G H | 4001 | 6637 | ORPHA:99027 | Adult-onset autosomal dominant leukodystrophy | | | | 44 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | LMNB1 CL E G H | 4001 | 6637 | OMIM:169500 | Leukodystrophy, adult-onset, autosomal dominant | | | | 44 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | LRPPRC CL E G H | 10128 | 15714 | ORPHA:70472 | Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type | | | | 191 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | LRRK2 CL E G H | 120892 | 18618 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040283 - Occasional | | | 221 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | LRRK2 CL E G H | 120892 | 18618 | OMIM:607060 | Parkinson disease 8, autosomal dominant | | | | 221 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | LRRK2 CL E G H | 120892 | 18618 | ORPHA:2828 | Young-onset Parkinson disease | | | | 221 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | LYST CL E G H | 1130 | 1968 | ORPHA:167 | Chédiak-Higashi syndrome | | | | 239 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPK10 CL E G H | 5602 | 6872 | ORPHA:2382 | Lennox-Gastaut syndrome | HP:0040282 - Frequent | | | 61 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | ORPHA:240071 | Classic progressive supranuclear palsy syndrome | HP:0040281 - Very frequent | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | OMIM:600274 | Frontotemporal dementia | | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | OMIM:168600 | Parkinson disease, late-onset | | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | OMIM:172700 | Pick disease of brain | | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | ORPHA:240103 | Progressive supranuclear palsy-corticobasal syndrome | HP:0040282 - Frequent | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | ORPHA:240085 | Progressive supranuclear palsy-parkinsonism syndrome | HP:0040282 - Frequent | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | ORPHA:240112 | Progressive supranuclear palsy-progressive non-fluent aphasia syndrome | HP:0040282 - Frequent | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | ORPHA:240094 | Progressive supranuclear palsy-pure akinesia with gait freezing syndrome | | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | ORPHA:100069 | Semantic dementia | | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | OMIM:260540 | Supranuclear palsy, progressive atypical | | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MAPT CL E G H | 4137 | 6893 | OMIM:601104 | Supranuclear palsy, progressive, 1 | | | | 140 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MATR3 CL E G H | 9782 | 6912 | OMIM:606070 | Amyotrophic lateral sclerosis 21 | | | | 80 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MATR3 CL E G H | 9782 | 6912 | ORPHA:600 | Vocal cord and pharyngeal distal myopathy | | | | 80 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:2273 | Ichthyosis follicularis-alopecia-photophobia syndrome | HP:0040282 - Frequent | | | 22 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MCOLN1 CL E G H | 57192 | 13356 | OMIM:252650 | Mucolipidosis IV | | | | 78 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MECP2 CL E G H | 4204 | 6990 | OMIM:312750 | Rett syndrome | | | | 950 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MFN2 CL E G H | 9927 | 16877 | OMIM:609260 | Charcot-marie-tooth disease, axonal, type 2A2A | HP:0040283 - Occasional | | | 203 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MFSD8 CL E G H | 256471 | 28486 | OMIM:610951 | Ceroid lipofuscinosis, neuronal, 7 | . | | | 120 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MICOS13 CL E G H | 125988 | 33702 | OMIM:618329 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37 | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | HP:0040283 - Occasional | | | 101 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MMACHC CL E G H | 25974 | 24525 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | | | | 101 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MPO CL E G H | 4353 | 7218 | OMIM:104300 | Alzheimer disease | | | | 11 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MTHFR CL E G H | 4524 | 7436 | ORPHA:395 | Homocystinuria due to methylene tetrahydrofolate reductase deficiency | HP:0040282 - Frequent | | | 183 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MTHFR CL E G H | 4524 | 7436 | OMIM:181500 | SCHIZOPHRENIA | | | | 183 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | MYORG CL E G H | 57462 | 19918 | OMIM:618317 | Basal ganglia calcification, idiopathic, 7, autosomal recessive | . | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NAGLU CL E G H | 4669 | 7632 | OMIM:252920 | Mucopolysaccharidosis type IIIB | | | | 72 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NBN CL E G H | 4683 | 7652 | ORPHA:647 | Nijmegen breakage syndrome | HP:0040281 - Very frequent | | | 706 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ND1 CL E G H | 4535 | 7455 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ND5 CL E G H | 4540 | 7461 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ND6 CL E G H | 4541 | 7462 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NDP CL E G H | 4693 | 7678 | OMIM:310600 | Norrie disease | | | | 39 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NDUFA6 CL E G H | 4700 | 7690 | OMIM:618253 | Mitochondrial complex I deficiency, nuclear type 33 | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NDUFAF3 CL E G H | 25915 | 29918 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 31 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NDUFB8 CL E G H | 4714 | 7703 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NDUFS2 CL E G H | 4720 | 7708 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NECAP1 CL E G H | 25977 | 24539 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NHLRC1 CL E G H | 378884 | 21576 | ORPHA:501 | Lafora disease | HP:0040282 - Frequent | | | 77 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NHLRC1 CL E G H | 378884 | 21576 | OMIM:254780 | Myoclonic epilepsy of lafora | | | | 77 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NOS3 CL E G H | 4846 | 7876 | OMIM:104300 | Alzheimer disease | | | | 8 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:603472 | NEURONAL INTRANUCLEAR INCLUSION DISEASE | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NOTCH2NLC CL E G H | 100996717 | 53924 | ORPHA:2289 | Neuronal intranuclear inclusion disease | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NOTCH3 CL E G H | 4854 | 7883 | OMIM:125310 | Cerebral arteriopathy, autosomal dominant, with subcortical infarctsand leukoencephalopathy | | | | 144 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NOTCH3 CL E G H | 4854 | 7883 | ORPHA:136 | Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy | | | | 144 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NPC1 CL E G H | 4864 | 7897 | OMIM:257220 | Niemann-pick disease, type C1 | | | | 258 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NPC2 CL E G H | 10577 | 14537 | OMIM:607625 | Niemann-pick disease, type C2 | | | | 33 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NR4A2 CL E G H | 4929 | 7981 | OMIM:168600 | Parkinson disease, late-onset | | | | 27 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NRAS CL E G H | 4893 | 7989 | OMIM:249400 | Neurocutaneous melanosis, somatic | . | | | 102 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NTRK2 CL E G H | 4915 | 8032 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 8 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | NUS1 CL E G H | 116150 | 21042 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | OPA1 CL E G H | 4976 | 8140 | ORPHA:98673 | Autosomal dominant optic atrophy, classic form | | | | 214 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PAH CL E G H | 5053 | 8582 | ORPHA:79254 | Classic phenylketonuria | HP:0040282 - Frequent | | | 641 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PANK2 CL E G H | 80025 | 15894 | OMIM:607236 | Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa,and pallidal degeneration | | | | 55 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PANK2 CL E G H | 80025 | 15894 | OMIM:234200 | Neurodegeneration with brain iron accumulation 1 | . | | | 55 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PARK7 CL E G H | 11315 | 16369 | ORPHA:2828 | Young-onset Parkinson disease | | | | 23 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PARS2 CL E G H | 25973 | 30563 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 14 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PDE10A CL E G H | 10846 | 8772 | OMIM:616922 | Striatal degeneration, autosomal dominant 2 | | | | 5 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PDE11A CL E G H | 50940 | 8773 | OMIM:610475 | Pigmented nodular adrenocortical disease, primary, 2 | . | | | 13 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PDGFB CL E G H | 5155 | 8800 | OMIM:213600 | Basal ganglia calcification, idiopathic, 1 | . | | | 9 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PDGFB CL E G H | 5155 | 8800 | OMIM:615483 | Basal ganglia calcification, idiopathic, 5 | | | | 9 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PDGFRB CL E G H | 5159 | 8804 | OMIM:213600 | Basal ganglia calcification, idiopathic, 1 | . | | | 28 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PDGFRB CL E G H | 5159 | 8804 | OMIM:615007 | Basal ganglia calcification, idiopathic, 4 | | | | 28 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PDGFRB CL E G H | 5159 | 8804 | OMIM:616592 | Kosaki overgrowth syndrome | | | | 28 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PINK1 CL E G H | 65018 | 14581 | OMIM:605909 | Parkinson disease 6, autosomal recessive early-onset | | | | 55 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PINK1 CL E G H | 65018 | 14581 | ORPHA:2828 | Young-onset Parkinson disease | | | | 55 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PLA2G6 CL E G H | 8398 | 9039 | ORPHA:199351 | Adult-onset dystonia-parkinsonism | | | | 133 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PLA2G6 CL E G H | 8398 | 9039 | ORPHA:35069 | Infantile neuroaxonal dystrophy | HP:0040282 - Frequent | | | 133 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PLA2G6 CL E G H | 8398 | 9039 | OMIM:610217 | Neurodegeneration with brain iron accumulation 2B | . | | | 133 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PLA2G6 CL E G H | 8398 | 9039 | OMIM:612953 | Parkinson disease 14, autosomal recessive | . | | | 133 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PLAU CL E G H | 5328 | 9052 | OMIM:104300 | Alzheimer disease | | | | 50 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PLEKHG4 CL E G H | 25894 | 24501 | ORPHA:98765 | Spinocerebellar ataxia type 4 | | | | 4 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PLP1 CL E G H | 5354 | 9086 | OMIM:312080 | Pelizaeus-Merzbacher disease | | | | 60 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PLP1 CL E G H | 5354 | 9086 | ORPHA:280229 | Pelizaeus-Merzbacher disease in female carriers | HP:0040283 - Occasional | | | 60 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PMPCA CL E G H | 23203 | 18667 | ORPHA:1170 | Autosomal recessive cerebelloparenchymal disorder type 3 | | | | 7 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PNPLA6 CL E G H | 10908 | 16268 | ORPHA:1173 | Cerebellar ataxia-hypogonadism syndrome | | | | 103 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PODXL CL E G H | 5420 | 9171 | ORPHA:2828 | Young-onset Parkinson disease | | | | 6 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | POLG CL E G H | 5428 | 9179 | OMIM:203700 | Mitochondrial DNA depletion syndrome 4A (Alpers type) | | | | 464 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | POLG CL E G H | 5428 | 9179 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 464 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | POLG CL E G H | 5428 | 9179 | OMIM:607459 | Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | | | | 464 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | POLR3K CL E G H | 51728 | 14121 | OMIM:619310 | LEUKODYSTROPHY, HYPOMYELINATING, 21; HLD21 | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PPP2R2B CL E G H | 5521 | 9305 | OMIM:604326 | Spinocerebellar ataxia 12 | | | | 5 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PPP2R2B CL E G H | 5521 | 9305 | ORPHA:98762 | Spinocerebellar ataxia type 12 | | | | 5 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PPP3CA CL E G H | 5530 | 9314 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PPT1 CL E G H | 5538 | 9325 | OMIM:256730 | Ceroid lipofuscinosis, neuronal, 1 | | | | 172 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRDM8 CL E G H | 56978 | 13993 | ORPHA:324290 | Early-onset Lafora body disease | HP:0040283 - Occasional | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRDM8 CL E G H | 56978 | 13993 | OMIM:616640 | Epilepsy, progressive myoclonic, 10 | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRDX1 CL E G H | 5052 | 9352 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRICKLE1 CL E G H | 144165 | 17019 | ORPHA:308 | Progressive myoclonic epilepsy type 1 | | | | 133 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRKAR1A CL E G H | 5573 | 9388 | OMIM:610489 | Pigmented nodular adrenocortical disease, primary, 1 | . | | | 134 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRKAR1B CL E G H | 5575 | 9390 | ORPHA:412066 | PRKAR1B-related neurodegenerative dementia with intermediate filaments | | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRKCG CL E G H | 5582 | 9402 | OMIM:605361 | Spinocerebellar ataxia 14 | . | | | 83 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRKN CL E G H | 5071 | 8607 | ORPHA:2828 | Young-onset Parkinson disease | | | | 138 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRNP CL E G H | 5621 | 9449 | OMIM:123400 | Creutzfeldt-Jakob disease | | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRNP CL E G H | 5621 | 9449 | OMIM:600072 | Fatal familial insomnia | | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRNP CL E G H | 5621 | 9449 | OMIM:137440 | Gerstmann-Straussler disease | | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRNP CL E G H | 5621 | 9449 | ORPHA:356 | Gerstmann-Straussler-Scheinker syndrome | HP:0040282 - Frequent | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRNP CL E G H | 5621 | 9449 | ORPHA:157941 | Huntington disease-like 1 | | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRNP CL E G H | 5621 | 9449 | OMIM:603218 | Huntington disease-like 1 | | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRNP CL E G H | 5621 | 9449 | ORPHA:282166 | Inherited Creutzfeldt-Jakob disease | | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRNP CL E G H | 5621 | 9449 | OMIM:245300 | KURU, SUSCEPTIBILITY TO | | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PRNP CL E G H | 5621 | 9449 | OMIM:606688 | Spongiform encephalopathy with neuropsychiatric features | | | | 69 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:206436 | Infantile Krabbe disease | HP:0040281 - Very frequent | | | 81 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSAP CL E G H | 5660 | 9498 | OMIM:611722 | KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY | | | | 81 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSAP CL E G H | 5660 | 9498 | OMIM:249900 | Metachromatic leukodystrophy due to saposin B deficiency | . | | | 81 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 81 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSAP CL E G H | 5660 | 9498 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 81 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN1 CL E G H | 5663 | 9508 | OMIM:607822 | Alzheimer disease 3 | | | | 241 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 241 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 241 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN1 CL E G H | 5663 | 9508 | OMIM:600274 | Frontotemporal dementia | | | | 241 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN1 CL E G H | 5663 | 9508 | OMIM:172700 | Pick disease of brain | | | | 241 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 241 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:100069 | Semantic dementia | | | | 241 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN2 CL E G H | 5664 | 9509 | OMIM:606889 | Alzheimer disease 4 | | | | 59 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN2 CL E G H | 5664 | 9509 | OMIM:613697 | Cardiomyopathy, dilated, 1V | | | | 59 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PSEN2 CL E G H | 5664 | 9509 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 59 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | PTS CL E G H | 5805 | 9689 | OMIM:261640 | Hyperphenylalaninemia, BH4-deficient, A | | | | 19 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | QDPR CL E G H | 5860 | 9752 | OMIM:261630 | Hyperphenylalaninemia, bh4-deficient, C | | | | 43 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RAB27A CL E G H | 5873 | 9766 | OMIM:607624 | Griscelli syndrome, type 2 | | | | 67 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RAB39B CL E G H | 116442 | 16499 | OMIM:311510 | Waisman syndrome | | | | 34 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RBM28 CL E G H | 55131 | 21863 | OMIM:612079 | Alopecia, neurologic defects, and endocrinopathy syndrome | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RBM28 CL E G H | 55131 | 21863 | ORPHA:157954 | ANE syndrome | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RNASEH1 CL E G H | 246243 | 18466 | ORPHA:329336 | Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy | | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RNF216 CL E G H | 54476 | 21698 | OMIM:212840 | Cerebellar ataxia and hypogonadotropic hypogonadism | | | | 10 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RNF216 CL E G H | 54476 | 21698 | ORPHA:1173 | Cerebellar ataxia-hypogonadism syndrome | | | | 10 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RNU4ATAC CL E G H | 100151683 | 34016 | OMIM:210710 | Microcephalic osteodysplastic primordial dwarfism, type I | | | | 15 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ROGDI CL E G H | 79641 | 29478 | ORPHA:1946 | Amelocerebrohypohidrotic syndrome | HP:0040281 - Very frequent | | | 57 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ROGDI CL E G H | 79641 | 29478 | OMIM:226750 | Kohlschutter-Tonz syndrome | | | | 57 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RRM2B CL E G H | 50484 | 17296 | ORPHA:329336 | Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy | | | | 125 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RRM2B CL E G H | 50484 | 17296 | OMIM:612075 | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) | | | | 125 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RRM2B CL E G H | 50484 | 17296 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 125 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | RTN4R CL E G H | 65078 | 18601 | OMIM:181500 | SCHIZOPHRENIA | | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SCARB2 CL E G H | 950 | 1665 | ORPHA:308 | Progressive myoclonic epilepsy type 1 | | | | 77 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SCN1A CL E G H | 6323 | 10585 | OMIM:607208 | Epileptic encephalopathy, early infantile, 6 (Dravet syndrome) | . | | | 1053 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SCN1A CL E G H | 6323 | 10585 | ORPHA:2382 | Lennox-Gastaut syndrome | HP:0040282 - Frequent | | | 1053 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SCN3A CL E G H | 6328 | 10590 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 70 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SCN8A CL E G H | 6334 | 10596 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 357 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SCO2 CL E G H | 9997 | 10604 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 40 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SDHA CL E G H | 6389 | 10680 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | | | | 304 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SDHAF1 CL E G H | 644096 | 33867 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | | | | 16 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SDHB CL E G H | 6390 | 10681 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | | | | 237 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SDHD CL E G H | 6392 | 10683 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | | | | 129 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SERPINI1 CL E G H | 5274 | 8943 | OMIM:604218 | Encephalopathy, familial, with neuroserpin inclusion bodies | | | | 28 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SGPL1 CL E G H | 8879 | 10817 | OMIM:617575 | Nephrotic syndrome, type 14 | . | | | 8 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC13A3 CL E G H | 64849 | 14430 | OMIM:618384 | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC13A5 CL E G H | 284111 | 23089 | ORPHA:1946 | Amelocerebrohypohidrotic syndrome | HP:0040281 - Very frequent | | | 73 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC13A5 CL E G H | 284111 | 23089 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 73 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC1A2 CL E G H | 6506 | 10940 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC1A3 CL E G H | 6507 | 10941 | ORPHA:2131 | Alternating hemiplegia of childhood | | | | 63 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC20A2 CL E G H | 6575 | 10947 | OMIM:213600 | Basal ganglia calcification, idiopathic, 1 | . | | | 70 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC2A3 CL E G H | 6515 | 11007 | ORPHA:399 | Huntington disease | HP:0040281 - Very frequent | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC38A3 CL E G H | 10991 | 18044 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC39A14 CL E G H | 23516 | 20858 | OMIM:617013 | Hypermanganesemia with dystonia 2 | | | | 5 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC44A1 CL E G H | 23446 | 18798 | OMIM:618868 | NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE; CONATOC | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SLC7A6OS CL E G H | 84138 | 25807 | OMIM:619191 | EPILEPSY, PROGRESSIVE MYOCLONIC, 12; EPM12 | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNCA CL E G H | 6622 | 11138 | OMIM:127750 | Dementia, lewy body | | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNCA CL E G H | 6622 | 11138 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040283 - Occasional | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNCA CL E G H | 6622 | 11138 | OMIM:168601 | Parkinson disease 1, autosomal dominant | . | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNCA CL E G H | 6622 | 11138 | OMIM:605543 | Parkinson disease 4 | | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNCA CL E G H | 6622 | 11138 | ORPHA:171695 | Parkinsonian-pyramidal syndrome | | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNCA CL E G H | 6622 | 11138 | ORPHA:2828 | Young-onset Parkinson disease | | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNCAIP CL E G H | 9627 | 11139 | OMIM:168600 | Parkinson disease, late-onset | | | | 35 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNCB CL E G H | 6620 | 11140 | OMIM:127750 | Dementia, lewy body | | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNORD118 CL E G H | 727676 | 32952 | ORPHA:542310 | Leukoencephalopathy with calcifications and cysts | | | | 6 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SNORD118 CL E G H | 727676 | 32952 | OMIM:614561 | Leukoencephalopathy, brain calcifications, and cysts | . | | | 6 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SORL1 CL E G H | 6653 | 11185 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SPAST CL E G H | 6683 | 11233 | OMIM:182601 | Spastic paraplegia 4, autosomal dominant | | | | 208 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SPG11 CL E G H | 80208 | 11226 | ORPHA:2822 | Autosomal recessive spastic paraplegia type 11 | HP:0040281 - Very frequent | | | 287 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SPG11 CL E G H | 80208 | 11226 | OMIM:604360 | Spastic paraplegia 11, autosomal recessive | . | | | 287 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SPG21 CL E G H | 51324 | 20373 | ORPHA:101001 | Autosomal recessive spastic paraplegia type 21 | HP:0040282 - Frequent | | | 28 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SPG21 CL E G H | 51324 | 20373 | OMIM:248900 | Mast syndrome | | | | 28 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SQSTM1 CL E G H | 8878 | 11280 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 62 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SQSTM1 CL E G H | 8878 | 11280 | OMIM:616437 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 | | | | 62 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SQSTM1 CL E G H | 8878 | 11280 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 62 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SQSTM1 CL E G H | 8878 | 11280 | OMIM:617145 | Neurodegeneration with ataxia, dystonia, and gaze palsy, childhood-onset | . | | | 62 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | STARD7 CL E G H | 56910 | 18063 | OMIM:607876 | Epilepsy, familial adult myoclonic, 2 | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | STUB1 CL E G H | 10273 | 11427 | OMIM:618093 | SPINOCEREBELLAR ATAXIA 48; SCA48 | | | | 14 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SUMF1 CL E G H | 285362 | 20376 | ORPHA:585 | Multiple sulfatase deficiency | | | | 80 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SUMF1 CL E G H | 285362 | 20376 | OMIM:272200 | Multiple sulfatase deficiency | | | | 80 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SURF1 CL E G H | 6834 | 11474 | ORPHA:70474 | Leigh syndrome with cardiomyopathy | HP:0040282 - Frequent | | | 73 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SYN2 CL E G H | 6854 | 11495 | OMIM:181500 | SCHIZOPHRENIA | | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SYNGAP1 CL E G H | 8831 | 11497 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 108 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SYNJ1 CL E G H | 8867 | 11503 | OMIM:617389 | Epileptic encephalopathy, early infantile, 53 | | | | 9 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SYNJ1 CL E G H | 8867 | 11503 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 9 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SYNJ1 CL E G H | 8867 | 11503 | OMIM:615530 | Parkinson disease 20, early-onset | HP:0040283 - Occasional | | | 9 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SYNJ1 CL E G H | 8867 | 11503 | ORPHA:2828 | Young-onset Parkinson disease | | | | 9 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | SZT2 CL E G H | 23334 | 29040 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 123 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TARDBP CL E G H | 23435 | 11571 | OMIM:612069 | Amyotrophic lateral sclerosis 10 with or without frontotemporal dementia | | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TARDBP CL E G H | 23435 | 11571 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 65 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TBK1 CL E G H | 29110 | 11584 | OMIM:617900 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8 | . | | | 20 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TBK1 CL E G H | 29110 | 11584 | OMIM:616439 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 | | | | 20 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TBK1 CL E G H | 29110 | 11584 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 20 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TBP CL E G H | 6908 | 11588 | OMIM:168600 | Parkinson disease, late-onset | | | | 7 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TBP CL E G H | 6908 | 11588 | OMIM:607136 | Spinocerebellar ataxia 17 | | | | 7 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TBP CL E G H | 6908 | 11588 | ORPHA:98759 | Spinocerebellar ataxia type 17 | HP:0040282 - Frequent | | | 7 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TIA1 CL E G H | 7072 | 11802 | OMIM:619133 | AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS26 | | | | 5 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TIMM8A CL E G H | 1678 | 11817 | OMIM:304700 | Mohr-Tranebjaerg syndrome | . | | | 15 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TIMM8A CL E G H | 1678 | 11817 | ORPHA:52368 | Mohr-Tranebjaerg syndrome | HP:0040282 - Frequent | | | 15 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TIMMDC1 CL E G H | 51300 | 1321 | OMIM:618251 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31 | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TINF2 CL E G H | 26277 | 11824 | OMIM:268130 | Revesz syndrome | | | | 60 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TK2 CL E G H | 7084 | 11831 | ORPHA:254875 | Mitochondrial DNA depletion syndrome, myopathic form | | | | 103 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TLR3 CL E G H | 7098 | 11849 | OMIM:613002 | Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2 | HP:0040284 - Very rare | | | 3 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TMEM106B CL E G H | 54664 | 22407 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TMEM106B CL E G H | 54664 | 22407 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TMEM106B CL E G H | 54664 | 22407 | ORPHA:100069 | Semantic dementia | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TMEM240 CL E G H | 339453 | 25186 | OMIM:607454 | Spinocerebellar ataxia 21 | | | | 9 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TOMM40 CL E G H | 10452 | 18001 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRAK1 CL E G H | 22906 | 29947 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TREM2 CL E G H | 54209 | 17761 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 31 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TREM2 CL E G H | 54209 | 17761 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 31 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TREM2 CL E G H | 54209 | 17761 | ORPHA:2770 | Nasu-Hakola disease | | | | 31 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TREM2 CL E G H | 54209 | 17761 | OMIM:618193 | POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL2 | | | | 31 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TREM2 CL E G H | 54209 | 17761 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 31 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TREM2 CL E G H | 54209 | 17761 | ORPHA:100069 | Semantic dementia | | | | 31 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TREX1 CL E G H | 11277 | 12269 | ORPHA:247691 | Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations | | | | 56 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TREX1 CL E G H | 11277 | 12269 | OMIM:192315 | Vasculopathy, retinal, with cerebral leukodystrophy | | | | 56 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNC CL E G H | 4511 | 7477 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNE CL E G H | 4556 | 7479 | ORPHA:2596 | Myopathy and diabetes mellitus | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNF CL E G H | 4558 | 7481 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNK CL E G H | 4566 | 7489 | ORPHA:1349 | Mitochondrial DNA-related cardiomyopathy and hearing loss | HP:0040282 - Frequent | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNK CL E G H | 4566 | 7489 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNL1 CL E G H | 4567 | 7490 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNQ CL E G H | 4572 | 7495 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNS1 CL E G H | 4574 | 7497 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNS2 CL E G H | 4575 | 7498 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNT CL E G H | 4576 | 7499 | OMIM:168600 | Parkinson disease, late-onset | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNV CL E G H | 4577 | 7500 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRNW CL E G H | 4578 | 7501 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TRPM7 CL E G H | 54822 | 17994 | OMIM:105500 | Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 | | | | 2 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TTPA CL E G H | 7274 | 12404 | ORPHA:96 | Ataxia with vitamin E deficiency | HP:0040283 - Occasional | | | 62 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TTR CL E G H | 7276 | 12405 | OMIM:105210 | Amyloidosis, hereditary, transthyretin-related | | | | 107 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TUBA4A CL E G H | 7277 | 12407 | OMIM:616208 | Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia | | | | 6 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TUBB4A CL E G H | 10382 | 20774 | ORPHA:98805 | Primary dystonia, DYT4 type | | | | 66 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TWNK CL E G H | 56652 | 1160 | OMIM:609286 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 | | | | 113 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TWNK CL E G H | 56652 | 1160 | OMIM:607459 | Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | | | | 113 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TYMP CL E G H | 1890 | 3148 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | | | | 138 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TYROBP CL E G H | 7305 | 12449 | ORPHA:2770 | Nasu-Hakola disease | | | | 22 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | TYROBP CL E G H | 7305 | 12449 | OMIM:221770 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy | | | | 22 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | UBA5 CL E G H | 79876 | 23230 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 13 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | UBAP1 CL E G H | 51271 | 12461 | OMIM:618418 | Spastic paraplegia 80, autosomal dominant | HP:0040284 - Very rare | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | UBQLN2 CL E G H | 29978 | 12509 | OMIM:300857 | Amyotrophic lateral sclerosis 15 with or without frontotemporal dementia | | | | 20 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | UBTF CL E G H | 7343 | 12511 | OMIM:617672 | Neurodegeneration, childhood-onset, with brain atrophy | . | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | UCHL1 CL E G H | 7345 | 12513 | ORPHA:2828 | Young-onset Parkinson disease | | | | 21 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VCP CL E G H | 7415 | 12666 | ORPHA:329478 | Adult-onset distal myopathy due to VCP mutation | | | | 63 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VCP CL E G H | 7415 | 12666 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 63 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VCP CL E G H | 7415 | 12666 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 63 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VCP CL E G H | 7415 | 12666 | OMIM:167320 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1 | | | | 63 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VCP CL E G H | 7415 | 12666 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | | | | 63 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VCP CL E G H | 7415 | 12666 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 63 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VPS13A CL E G H | 23230 | 1908 | OMIM:200150 | CHOREOACANTHOCYTOSIS | | | | 130 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VPS13A CL E G H | 23230 | 1908 | ORPHA:2388 | Choreoacanthocytosis | HP:0040283 - Occasional | | | 130 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VPS13C CL E G H | 54832 | 23594 | OMIM:616840 | Parkinson disease 23, autosomal recessive early-onset | | | | 8 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VPS13C CL E G H | 54832 | 23594 | ORPHA:2828 | Young-onset Parkinson disease | | | | 8 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | VPS35 CL E G H | 55737 | 13487 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040283 - Occasional | | | 37 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | WDR45 CL E G H | 11152 | 28912 | ORPHA:329284 | Beta-propeller protein-associated neurodegeneration | | | | 51 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | WDR45 CL E G H | 11152 | 28912 | OMIM:300894 | Neurodegeneration with brain iron accumulation 5 | | | | 51 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | WFS1 CL E G H | 7466 | 12762 | ORPHA:3463 | Wolfram syndrome | | | | 389 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | WFS1 CL E G H | 7466 | 12762 | ORPHA:411590 | Wolfram-like syndrome | | | | 389 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | WWOX CL E G H | 51741 | 12799 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | 149 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | XPA CL E G H | 7507 | 12814 | OMIM:278700 | Xeroderma pigmentosum, complementation group A | . | | | 34 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | XPR1 CL E G H | 9213 | 12827 | OMIM:616413 | Basal ganglia calcification, idiopathic, 6 | | | | 4 | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | YWHAG CL E G H | 7532 | 12852 | ORPHA:442835 | Non-specific early-onset epileptic encephalopathy | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0001268 | Mental deterioration | 0 | ZFYVE26 CL E G H | 23503 | 20761 | ORPHA:100996 | Autosomal recessive spastic paraplegia type 15 | | | | 189 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | AARS1 CL E G H | 16 | 20 | OMIM:619661 | LEUKOENCEPHALOPATHY, HEREDITARY DIFFUSE, WITH SPHEROIDS 2; HDLS2 | | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | AARS2 CL E G H | 57505 | 21022 | OMIM:615889 | Leukoencephalopathy, progressive, with ovarian failure | . | | | 143 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ABCA7 CL E G H | 10347 | 37 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 3 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ABCD1 CL E G H | 215 | 61 | OMIM:300100 | Adrenoleukodystrophy | . | | | 135 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ADA2 CL E G H | 51816 | 1839 | ORPHA:820 | Sneddon syndrome | HP:0040282 - Frequent | | | 22 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ADH1C CL E G H | 126 | 251 | OMIM:168600 | Parkinson disease, late-onset | . | | | 4 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ALDH18A1 CL E G H | 5832 | 9722 | ORPHA:447753 | Autosomal dominant spastic paraplegia type 9A | HP:0040283 - Occasional | | | 89 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | ALDH18A1 CL E G H | 5832 | 9722 | ORPHA:447757 | Autosomal dominant spastic paraplegia type 9B | HP:0040282 - Frequent | | | 89 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ALDH18A1 CL E G H | 5832 | 9722 | ORPHA:447757 | Autosomal dominant spastic paraplegia type 9B | HP:0040283 - Occasional | | | 89 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APOE CL E G H | 348 | 613 | OMIM:104310 | Alzheimer disease 2 | . | | | 39 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APOE CL E G H | 348 | 613 | OMIM:607822 | Alzheimer disease 3 | . | | | 39 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APOE CL E G H | 348 | 613 | OMIM:606889 | Alzheimer disease 4 | | | | 39 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | APOL2 CL E G H | 23780 | 619 | OMIM:181500 | SCHIZOPHRENIA | . | | | | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | APOL4 CL E G H | 80832 | 14867 | OMIM:181500 | SCHIZOPHRENIA | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APP CL E G H | 351 | 620 | ORPHA:100006 | ABeta amyloidosis, Dutch type | HP:0040281 - Very frequent | | | 74 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APP CL E G H | 351 | 620 | ORPHA:324708 | ABeta amyloidosis, Iowa type | HP:0040281 - Very frequent | | | 74 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APP CL E G H | 351 | 620 | ORPHA:324713 | ABeta amyloidosis, Italian type | HP:0040282 - Frequent | | | 74 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APP CL E G H | 351 | 620 | ORPHA:324703 | ABetaL34V amyloidosis | HP:0040281 - Very frequent | | | 74 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APP CL E G H | 351 | 620 | OMIM:104300 | Alzheimer disease | . | | | 74 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APP CL E G H | 351 | 620 | OMIM:605714 | Cerebral amyloid angiopathy, APP-related | . | | | 74 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APP CL E G H | 351 | 620 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 74 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | APTX CL E G H | 54840 | 15984 | OMIM:208920 | Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia | . | | | 61 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040282 - Frequent | | | 253 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 253 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | ARSA CL E G H | 410 | 713 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 253 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ASAH1 CL E G H | 427 | 735 | OMIM:159950 | Spinal muscular atrophy with progressive myoclonic epilepsy | . | | | 78 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATN1 CL E G H | 1822 | 3033 | ORPHA:101 | Dentatorubral pallidoluysian atrophy | HP:0040282 - Frequent | | | 16 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATN1 CL E G H | 1822 | 3033 | OMIM:125370 | Dentatorubral-Pallidoluysian atrophy naito-oyanagi disease haw river syndrome ataxia, chorea, seizures, and dementia | | | | 16 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP13A2 CL E G H | 23400 | 30213 | ORPHA:513436 | Autosomal recessive spastic paraplegia type 78 | HP:0040284 - Very rare | | | 100 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP13A2 CL E G H | 23400 | 30213 | ORPHA:306674 | Kufor-Rakeb syndrome | HP:0040281 - Very frequent | | | 100 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP13A2 CL E G H | 23400 | 30213 | OMIM:606693 | Kufor-Rakeb syndrome | | | | 100 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP13A2 CL E G H | 23400 | 30213 | OMIM:617225 | SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE; SPG78 | | | | 100 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | ATP1A2 CL E G H | 477 | 800 | ORPHA:2131 | Alternating hemiplegia of childhood | HP:0040283 - Occasional | | | 239 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | ATP1A3 CL E G H | 478 | 801 | ORPHA:2131 | Alternating hemiplegia of childhood | HP:0040283 - Occasional | | | 150 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP6 CL E G H | 4508 | 7414 | ORPHA:644 | NARP syndrome | HP:0040282 - Frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP6 CL E G H | 4508 | 7414 | OMIM:551500 | Neuropathy, ataxia, and retinitis pigmentosa | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | HP:0040281 - Very frequent | | | 140 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | ATP6V0A2 CL E G H | 23545 | 18481 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | HP:0040281 - Very frequent | | | 140 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | ATP6V1A CL E G H | 523 | 851 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | HP:0040281 - Very frequent | | | 3 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP6V1A CL E G H | 523 | 851 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | HP:0040281 - Very frequent | | | 3 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP6V1E1 CL E G H | 529 | 857 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | HP:0040281 - Very frequent | | | 2 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | ATP6V1E1 CL E G H | 529 | 857 | ORPHA:357074 | Autosomal recessive cutis laxa type 2, classic type | HP:0040281 - Very frequent | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | . | | | 315 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATRX CL E G H | 546 | 886 | ORPHA:96253 | Cushing disease | | | | 169 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATXN10 CL E G H | 25814 | 10549 | OMIM:603516 | Spinocerebellar ataxia 10 | . | | | 9 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATXN2 CL E G H | 6311 | 10555 | OMIM:168600 | Parkinson disease, late-onset | . | | | 11 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATXN2 CL E G H | 6311 | 10555 | OMIM:183090 | Spinocerebellar ataxia 2 | . | | | 11 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATXN2 CL E G H | 6311 | 10555 | ORPHA:98756 | Spinocerebellar ataxia type 2 | HP:0040282 - Frequent | | | 11 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATXN3 CL E G H | 4287 | 7106 | OMIM:109150 | Machado-Joseph disease | . | | | 14 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ATXN8OS CL E G H | 6315 | 10561 | OMIM:168600 | Parkinson disease, late-onset | . | | | 1 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | AUH CL E G H | 549 | 890 | OMIM:250950 | 3-methylglutaconic aciduria, type I | | | | 49 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | BRAF CL E G H | 673 | 1097 | ORPHA:96253 | Cushing disease | | | | 276 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:363400 | Severe neurodegenerative syndrome with lipodystrophy | | | | 105 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | C19ORF12 CL E G H | 83636 | 25443 | OMIM:614298 | Neurodegeneration with brain iron accumulation 4 | . | | | 114 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | C9ORF72 CL E G H | 203228 | 28337 | OMIM:105550 | Amyotrophic lateral sclerosis and/or frontotemporal dementia 1 | . | | | 56 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | | | | 56 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 56 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:100070 | Progressive non-fluent aphasia | | | | 56 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:100069 | Semantic dementia | HP:0040282 - Frequent | | | 56 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | CACNA1A CL E G H | 773 | 1388 | ORPHA:2131 | Alternating hemiplegia of childhood | HP:0040283 - Occasional | | | 449 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CCNF CL E G H | 899 | 1591 | OMIM:619141 | FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 5; FTDALS5 | | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CDH23 CL E G H | 64072 | 13733 | ORPHA:96253 | Cushing disease | | | | 636 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CERS1 CL E G H | 10715 | 14253 | OMIM:616230 | Epilepsy, progressive myoclonic, 8 | . | | | 1 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | CERS1 CL E G H | 10715 | 14253 | OMIM:616230 | Epilepsy, progressive myoclonic, 8 | | | | 1 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CFAP43 CL E G H | 80217 | 26684 | OMIM:236690 | Hydrocephalus, normal pressure, 1 | . | | | 6 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CHCHD10 CL E G H | 400916 | 15559 | OMIM:615911 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 | | | | 11 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CHCHD10 CL E G H | 400916 | 15559 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 11 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | CHI3L1 CL E G H | 1116 | 1932 | OMIM:181500 | SCHIZOPHRENIA | . | | | 1 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CHMP2B CL E G H | 25978 | 24537 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | | | | 42 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CHMP2B CL E G H | 25978 | 24537 | OMIM:600795 | Frontotemporal dementia and/or amytrophic lateral sclerosis 7 | | | | 42 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CHMP2B CL E G H | 25978 | 24537 | ORPHA:100070 | Progressive non-fluent aphasia | | | | 42 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CHMP2B CL E G H | 25978 | 24537 | ORPHA:100069 | Semantic dementia | HP:0040282 - Frequent | | | 42 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CISD2 CL E G H | 493856 | 24212 | ORPHA:3463 | Wolfram syndrome | HP:0040283 - Occasional | | | 3 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | CLN3 CL E G H | 1201 | 2074 | OMIM:204200 | Ceroid lipofuscinosis, neuronal, 3 | . | | | 216 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CLN3 CL E G H | 1201 | 2074 | OMIM:204200 | Ceroid lipofuscinosis, neuronal, 3 | . | | | 216 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CLN3 CL E G H | 1201 | 2074 | ORPHA:228346 | CLN3 disease | | | | 216 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | CLN5 CL E G H | 1203 | 2076 | OMIM:256731 | Ceroid lipofuscinosis, neuronal, 5 | . | | | 141 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CLN6 CL E G H | 54982 | 2077 | OMIM:204300 | Ceroid lipofuscinosis, neuronal, 4A, autosomal recessive | . | | | 143 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | CLN6 CL E G H | 54982 | 2077 | OMIM:601780 | Ceroid lipofuscinosis, neuronal, 6 | . | | | 143 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | CLN8 CL E G H | 2055 | 2079 | ORPHA:1947 | Progressive epilepsy-intellectual disability syndrome, Finnish type | HP:0040282 - Frequent | | | 111 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CLN8 CL E G H | 2055 | 2079 | ORPHA:1947 | Progressive epilepsy-intellectual disability syndrome, Finnish type | HP:0040283 - Occasional | | | 111 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | CNTNAP2 CL E G H | 26047 | 13830 | ORPHA:163681 | CNTNAP2-related developmental and epileptic encephalopathy | | | | 518 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | CNTNAP2 CL E G H | 26047 | 13830 | OMIM:610042 | Pitt-Hopkins-Like syndrome 1 | | | | 518 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | COG2 CL E G H | 22796 | 6546 | ORPHA:435934 | COG2-CDG | | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | COL4A1 CL E G H | 1282 | 2202 | OMIM:618564 | MICROANGIOPATHY AND LEUKOENCEPHALOPATHY, PONTINE, AUTOSOMAL DOMINANT; PADMAL | | | | 193 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | COMT CL E G H | 1312 | 2228 | OMIM:181500 | SCHIZOPHRENIA | . | | | 6 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | COX1 CL E G H | 4512 | 7419 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | COX1 CL E G H | 4512 | 7419 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | COX2 CL E G H | 4513 | 7421 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | COX2 CL E G H | 4513 | 7421 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | COX3 CL E G H | 4514 | 7422 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | COX3 CL E G H | 4514 | 7422 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CP CL E G H | 1356 | 2295 | OMIM:604290 | ACERULOPLASMINEMIA | . | | | 115 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353281 | Rubinstein-Taybi syndrome due to 16p13.3 microdeletion | HP:0040282 - Frequent | | | 291 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | CREBBP CL E G H | 1387 | 2348 | ORPHA:353277 | Rubinstein-Taybi syndrome due to CREBBP mutations | HP:0040282 - Frequent | | | 291 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CSF1R CL E G H | 1436 | 2433 | OMIM:221820 | Leukoencephalopathy, diffuse hereditary, with spheroids | | | | 149 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CST3 CL E G H | 1471 | 2475 | OMIM:105150 | Amyloidosis VI | . | | | 3 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CSTB CL E G H | 1476 | 2482 | OMIM:254800 | Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg) | | | | 51 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CSTB CL E G H | 1476 | 2482 | ORPHA:308 | Progressive myoclonic epilepsy type 1 | HP:0040283 - Occasional | | | 51 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | CTNS CL E G H | 1497 | 2518 | OMIM:219800 | Cystinosis, nephropathic | . | | | 178 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CTSF CL E G H | 8722 | 2531 | OMIM:615362 | Ceroid lipofuscinosis, neuronal, 13 | . | | | 20 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CUBN CL E G H | 8029 | 2548 | OMIM:261100 | Megaloblastic anemia 1 | . | | | 273 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | CYC1 CL E G H | 1537 | 2579 | OMIM:615453 | Mitochondrial complex III deficiency, nuclear type 6 | | | | 12 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CYLD CL E G H | 1540 | 2584 | OMIM:619132 | FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 8; FTDALS8 | | | | 126 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CYP27A1 CL E G H | 1593 | 2605 | OMIM:213700 | Cerebrotendinous xanthomatosis | | | | 114 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | CYP27A1 CL E G H | 1593 | 2605 | ORPHA:909 | Cerebrotendinous xanthomatosis | | | | 114 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | CYTB CL E G H | 4519 | 7427 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | DAOA CL E G H | 267012 | 21191 | OMIM:181500 | SCHIZOPHRENIA | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DCTN1 CL E G H | 1639 | 2711 | OMIM:168605 | Perry syndrome | | | | 86 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DCTN1 CL E G H | 1639 | 2711 | ORPHA:178509 | Perry syndrome | HP:0040283 - Occasional | | | 86 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DGUOK CL E G H | 1716 | 2858 | ORPHA:329314 | Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency | HP:0040283 - Occasional | | | 57 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | DISC2 CL E G H | 27184 | 2889 | OMIM:181500 | SCHIZOPHRENIA | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DLAT CL E G H | 1737 | 2896 | ORPHA:79244 | Pyruvate dehydrogenase E2 deficiency | HP:0040283 - Occasional | | | 82 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DNAJC13 CL E G H | 23317 | 30343 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040284 - Very rare | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DNAJC5 CL E G H | 80331 | 16235 | OMIM:162350 | Ceroid lipofuscinosis, neuronal, 4B, autosomal dominant | . | | | 155 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DNAJC6 CL E G H | 9829 | 15469 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 6 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DNM1L CL E G H | 10059 | 2973 | ORPHA:98673 | Autosomal dominant optic atrophy, classic form | HP:0040284 - Very rare | | | 94 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DNMT1 CL E G H | 1786 | 2976 | OMIM:604121 | Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant | . | | | 145 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | DNMT1 CL E G H | 1786 | 2976 | OMIM:614116 | Neuropathy, hereditary sensory, type IE | . | HP:0003581 - Adult onset | | 145 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | DRD3 CL E G H | 1814 | 3024 | OMIM:181500 | SCHIZOPHRENIA | . | | | 21 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | EIF4G1 CL E G H | 1981 | 3296 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040284 - Very rare | | | 2 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | EP300 CL E G H | 2033 | 3373 | ORPHA:353284 | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | HP:0040282 - Frequent | | | 250 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | EPM2A CL E G H | 7957 | 3413 | ORPHA:501 | Lafora disease | HP:0040282 - Frequent | | | 83 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | EPM2A CL E G H | 7957 | 3413 | OMIM:254780 | Myoclonic epilepsy of lafora | . | | | 83 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | EPM2A CL E G H | 7957 | 3413 | OMIM:254780 | Myoclonic epilepsy of lafora | . | | | 83 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ERCC4 CL E G H | 2072 | 3436 | OMIM:278760 | Xeroderma pigmentosum, complementation group F | HP:0040283 - Occasional | | | 158 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | ERCC6 CL E G H | 2074 | 3438 | OMIM:214150 | Cerebrooculofacioskeletal syndrome 1 | | | | 199 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | ERCC6 CL E G H | 2074 | 3438 | ORPHA:90324 | Cockayne syndrome type 3 | HP:0040283 - Occasional | | | 199 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ERCC8 CL E G H | 1161 | 3439 | OMIM:216400 | Cockayne syndrome A | . | | | 55 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | ERCC8 CL E G H | 1161 | 3439 | ORPHA:90324 | Cockayne syndrome type 3 | HP:0040283 - Occasional | | | 55 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | FAR1 CL E G H | 84188 | 26222 | ORPHA:447753 | Autosomal dominant spastic paraplegia type 9A | HP:0040283 - Occasional | | | 7 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | FBXO7 CL E G H | 25793 | 13586 | ORPHA:171695 | Parkinsonian-pyramidal syndrome | HP:0040283 - Occasional | | | 36 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | FMR1 CL E G H | 2332 | 3775 | OMIM:300623 | Fragile X tremor/ataxia syndrome | | | | 30 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | FMR1 CL E G H | 2332 | 3775 | ORPHA:93256 | Fragile X-associated tremor/ataxia syndrome | HP:0040281 - Very frequent | | | 30 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | FRRS1L CL E G H | 23732 | 1362 | ORPHA:725 | Continuous spikes and waves during sleep | HP:0040283 - Occasional | | | 4 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | FTL CL E G H | 2512 | 3999 | OMIM:606159 | Neurodegeneration with brain iron accumulation 3 | . | | | 33 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | FTL CL E G H | 2512 | 3999 | ORPHA:157846 | Neuroferritinopathy | | | | 33 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | FUS CL E G H | 2521 | 4010 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 105 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | GALC CL E G H | 2581 | 4115 | ORPHA:206448 | Adult Krabbe disease | HP:0040283 - Occasional | | | 160 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | GALC CL E G H | 2581 | 4115 | ORPHA:206436 | Infantile Krabbe disease | HP:0040281 - Very frequent | | | 160 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | GALC CL E G H | 2581 | 4115 | ORPHA:206436 | Infantile Krabbe disease | HP:0040282 - Frequent | | | 160 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | GALC CL E G H | 2581 | 4115 | OMIM:245200 | Krabbe disease | . | | | 160 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | GALK1 CL E G H | 2584 | 4118 | ORPHA:79237 | Galactokinase deficiency | HP:0040284 - Very rare | | | 23 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:127750 | Dementia, lewy body | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GBA1 CL E G H | 2629 | 4177 | ORPHA:77261 | Gaucher disease type 3 | HP:0040282 - Frequent | | | | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:608013 | Gaucher disease, perinatal lethal | . | | | | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:230900 | Gaucher disease, type II | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:231000 | Gaucher disease, type III | . | | | | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:231000 | Gaucher disease, type III | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GBA1 CL E G H | 2629 | 4177 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040284 - Very rare | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GBA1 CL E G H | 2629 | 4177 | OMIM:168600 | Parkinson disease, late-onset | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GBA2 CL E G H | 57704 | 18986 | ORPHA:320391 | Autosomal recessive spastic paraplegia type 46 | HP:0040283 - Occasional | | | 30 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GBA2 CL E G H | 57704 | 18986 | OMIM:614409 | Spastic paraplegia 46, autosomal recessive | HP:0040283 - Occasional | | | 30 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GBE1 CL E G H | 2632 | 4180 | ORPHA:206583 | Adult polyglucosan body disease | HP:0040283 - Occasional | | | 86 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GCDH CL E G H | 2639 | 4189 | ORPHA:25 | Glutaryl-CoA dehydrogenase deficiency | HP:0040283 - Occasional | | | 115 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | GCH1 CL E G H | 2643 | 4193 | OMIM:233910 | Hyperphenylalaninemia, BH4-deficient, B | . | | | 86 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GIGYF2 CL E G H | 26058 | 11960 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040284 - Very rare | | | 8 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | GLB1 CL E G H | 2720 | 4298 | OMIM:230600 | Gm1-gangliosidosis, type II | | | | 120 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GLUD2 CL E G H | 2747 | 4336 | OMIM:168600 | Parkinson disease, late-onset | . | | | 1 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GM2A CL E G H | 2760 | 4367 | OMIM:272750 | Gm2-Gangliosidosis, ab variant | . | | | 69 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | GRIN2A CL E G H | 2903 | 4585 | ORPHA:725 | Continuous spikes and waves during sleep | HP:0040283 - Occasional | | | 434 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | GRIN2A CL E G H | 2903 | 4585 | ORPHA:98818 | Landau-Kleffner syndrome | HP:0040282 - Frequent | | | 434 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GRN CL E G H | 2896 | 4601 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | | | | 126 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GRN CL E G H | 2896 | 4601 | OMIM:607485 | Frontotemporal lobar degeneration with TDP43 inclusions | | | | 126 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | GRN CL E G H | 2896 | 4601 | OMIM:607485 | Frontotemporal lobar degeneration with TDP43 inclusions | | | | 126 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GRN CL E G H | 2896 | 4601 | ORPHA:100070 | Progressive non-fluent aphasia | | | | 126 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | GRN CL E G H | 2896 | 4601 | ORPHA:100069 | Semantic dementia | HP:0040282 - Frequent | | | 126 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | HEPACAM CL E G H | 220296 | 26361 | OMIM:613925 | Megalencephalic leukoencephalopathy with subcortical cysts 2A | . | | | 82 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | HEXB CL E G H | 3074 | 4879 | OMIM:268800 | Sandhoff disease | | | | 80 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HFE CL E G H | 3077 | 4886 | OMIM:104300 | Alzheimer disease | . | | | 38 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | HGSNAT CL E G H | 138050 | 26527 | OMIM:252930 | Mucopolysaccharidosis type IIIC | . | | | 86 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | HIBCH CL E G H | 26275 | 4908 | ORPHA:88639 | Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency | HP:0040281 - Very frequent | | | 32 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HLA-DQB1 CL E G H | 3119 | 4944 | OMIM:123400 | Creutzfeldt-Jakob disease | . | | | | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | HNF4A CL E G H | 3172 | 5024 | ORPHA:263455 | Hyperinsulinism due to HNF4A deficiency | HP:0040282 - Frequent | | | 138 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HNRNPA1 CL E G H | 3178 | 5031 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | | | | 31 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HNRNPA2B1 CL E G H | 3181 | 5033 | OMIM:615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | | | | 5 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HNRNPA2B1 CL E G H | 3181 | 5033 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | | | | 5 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | HSD17B10 CL E G H | 3028 | 4800 | OMIM:300438 | HSD10 mitochondrial disease | . | | | 19 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | HTR2A CL E G H | 3356 | 5293 | OMIM:181500 | SCHIZOPHRENIA | . | | | 4 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HTRA1 CL E G H | 5654 | 9476 | OMIM:600142 | Autosomal recessive cerebral arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) | . | | | 34 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HTRA1 CL E G H | 5654 | 9476 | OMIM:616779 | Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 | . | | | 34 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HTRA1 CL E G H | 5654 | 9476 | ORPHA:199354 | Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy | | | | 34 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HTRA2 CL E G H | 27429 | 14348 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 39 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HTT CL E G H | 3064 | 4851 | OMIM:143100 | Huntington disease | . | | | 12 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | HTT CL E G H | 3064 | 4851 | ORPHA:248111 | Juvenile Huntington disease | HP:0040282 - Frequent | | | 12 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | IDUA CL E G H | 3425 | 5391 | OMIM:607014 | Hurler syndrome | . | | | 115 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | IRF6 CL E G H | 3664 | 6121 | OMIM:119500 | Popliteal pterygium syndrome | . | | | 99 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ITM2B CL E G H | 9445 | 6174 | OMIM:176500 | Cerebral amyloid angiopathy, itm2b-related, 1 | . | | | 3 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | ITM2B CL E G H | 9445 | 6174 | OMIM:176500 | Cerebral amyloid angiopathy, itm2b-related, 1 | . | | | 3 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ITM2B CL E G H | 9445 | 6174 | OMIM:117300 | Dementia, familial danish | . | | | 3 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | JPH3 CL E G H | 57338 | 14203 | OMIM:606438 | Huntington disease-like 2 | . | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | JPH3 CL E G H | 57338 | 14203 | ORPHA:98934 | Huntington disease-like 2 | HP:0040283 - Occasional | | | 2 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | KARS1 CL E G H | 3735 | 6215 | OMIM:619196 | DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE | | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | KCTD7 CL E G H | 154881 | 21957 | ORPHA:263516 | Progressive myoclonic epilepsy type 3 | HP:0040283 - Occasional | | | 106 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | KCTD7 CL E G H | 154881 | 21957 | ORPHA:263516 | Progressive myoclonic epilepsy type 3 | | | | 106 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | KMT2A CL E G H | 4297 | 7132 | ORPHA:319182 | Wiedemann-Steiner syndrome | HP:0040283 - Occasional | | | 91 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | LIG3 CL E G H | 3980 | 6600 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040284 - Very rare | | | 1 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | LMNB1 CL E G H | 4001 | 6637 | ORPHA:99027 | Adult-onset autosomal dominant leukodystrophy | HP:0040284 - Very rare | | | 44 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | LMNB1 CL E G H | 4001 | 6637 | OMIM:169500 | Leukodystrophy, adult-onset, autosomal dominant | . | | | 44 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | LRPPRC CL E G H | 10128 | 15714 | ORPHA:70472 | Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type | HP:0040282 - Frequent | | | 191 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | LRRK2 CL E G H | 120892 | 18618 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040284 - Very rare | | | 221 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | LRRK2 CL E G H | 120892 | 18618 | OMIM:607060 | Parkinson disease 8, autosomal dominant | . | | | 221 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | LRRK2 CL E G H | 120892 | 18618 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 221 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | LYST CL E G H | 1130 | 1968 | ORPHA:167 | Chédiak-Higashi syndrome | HP:0040283 - Occasional | | | 239 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MAPT CL E G H | 4137 | 6893 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | | | | 140 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | MAPT CL E G H | 4137 | 6893 | ORPHA:240071 | Classic progressive supranuclear palsy syndrome | HP:0040283 - Occasional | | | 140 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MAPT CL E G H | 4137 | 6893 | OMIM:600274 | Frontotemporal dementia | | | | 140 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MAPT CL E G H | 4137 | 6893 | OMIM:168600 | Parkinson disease, late-onset | . | | | 140 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MAPT CL E G H | 4137 | 6893 | OMIM:172700 | Pick disease of brain | | | | 140 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MAPT CL E G H | 4137 | 6893 | ORPHA:100070 | Progressive non-fluent aphasia | | | | 140 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MAPT CL E G H | 4137 | 6893 | ORPHA:240094 | Progressive supranuclear palsy-pure akinesia with gait freezing syndrome | HP:0040283 - Occasional | | | 140 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MAPT CL E G H | 4137 | 6893 | ORPHA:100069 | Semantic dementia | HP:0040282 - Frequent | | | 140 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MAPT CL E G H | 4137 | 6893 | OMIM:260540 | Supranuclear palsy, progressive atypical | . | | | 140 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MAPT CL E G H | 4137 | 6893 | OMIM:601104 | Supranuclear palsy, progressive, 1 | | | | 140 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MATR3 CL E G H | 9782 | 6912 | OMIM:606070 | Amyotrophic lateral sclerosis 21 | HP:0040283 - Occasional | | | 80 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MATR3 CL E G H | 9782 | 6912 | ORPHA:600 | Vocal cord and pharyngeal distal myopathy | HP:0040284 - Very rare | | | 80 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MBTPS2 CL E G H | 51360 | 15455 | ORPHA:2273 | Ichthyosis follicularis-alopecia-photophobia syndrome | HP:0040282 - Frequent | | | 22 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | MCOLN1 CL E G H | 57192 | 13356 | OMIM:252650 | Mucolipidosis IV | . | | | 78 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | MECP2 CL E G H | 4204 | 6990 | OMIM:312750 | Rett syndrome | . | | | 950 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | MICOS13 CL E G H | 125988 | 33702 | OMIM:618329 | COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37 | | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MMACHC CL E G H | 25974 | 24525 | ORPHA:79282 | Methylmalonic acidemia with homocystinuria, type cblC | HP:0040284 - Very rare | | | 101 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MMACHC CL E G H | 25974 | 24525 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | 101 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | MPO CL E G H | 4353 | 7218 | OMIM:104300 | Alzheimer disease | . | | | 11 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | MTHFR CL E G H | 4524 | 7436 | OMIM:181500 | SCHIZOPHRENIA | . | | | 183 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | NAGLU CL E G H | 4669 | 7632 | OMIM:252920 | Mucopolysaccharidosis type IIIB | . | | | 72 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ND1 CL E G H | 4535 | 7455 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ND1 CL E G H | 4535 | 7455 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ND4 CL E G H | 4538 | 7459 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ND5 CL E G H | 4540 | 7461 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ND5 CL E G H | 4540 | 7461 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ND6 CL E G H | 4541 | 7462 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ND6 CL E G H | 4541 | 7462 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NDP CL E G H | 4693 | 7678 | OMIM:310600 | Norrie disease | . | | | 39 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | NDUFA6 CL E G H | 4700 | 7690 | OMIM:618253 | Mitochondrial complex I deficiency, nuclear type 33 | . | | | 1 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NHLRC1 CL E G H | 378884 | 21576 | ORPHA:501 | Lafora disease | HP:0040282 - Frequent | | | 77 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NHLRC1 CL E G H | 378884 | 21576 | OMIM:254780 | Myoclonic epilepsy of lafora | . | | | 77 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | NHLRC1 CL E G H | 378884 | 21576 | OMIM:254780 | Myoclonic epilepsy of lafora | . | | | 77 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NOS3 CL E G H | 4846 | 7876 | OMIM:104300 | Alzheimer disease | . | | | 8 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NOTCH2NLC CL E G H | 100996717 | 53924 | ORPHA:2289 | Neuronal intranuclear inclusion disease | HP:0040282 - Frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NOTCH2NLC CL E G H | 100996717 | 53924 | OMIM:603472 | NEURONAL INTRANUCLEAR INCLUSION DISEASE | | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NOTCH3 CL E G H | 4854 | 7883 | OMIM:125310 | Cerebral arteriopathy, autosomal dominant, with subcortical infarctsand leukoencephalopathy | | | | 144 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NOTCH3 CL E G H | 4854 | 7883 | ORPHA:136 | Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy | HP:0040283 - Occasional | | | 144 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | NOTCH3 CL E G H | 4854 | 7883 | ORPHA:136 | Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy | HP:0040283 - Occasional | | | 144 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NPC1 CL E G H | 4864 | 7897 | OMIM:257220 | Niemann-pick disease, type C1 | . | | | 258 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NPC2 CL E G H | 10577 | 14537 | OMIM:607625 | Niemann-pick disease, type C2 | . | | | 33 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NR3C1 CL E G H | 2908 | 7978 | ORPHA:96253 | Cushing disease | | | | 79 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | NR4A2 CL E G H | 4929 | 7981 | OMIM:168600 | Parkinson disease, late-onset | . | | | 27 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | OPA1 CL E G H | 4976 | 8140 | ORPHA:98673 | Autosomal dominant optic atrophy, classic form | HP:0040284 - Very rare | | | 214 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | PAH CL E G H | 5053 | 8582 | ORPHA:79254 | Classic phenylketonuria | HP:0040283 - Occasional | | | 641 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PANK2 CL E G H | 80025 | 15894 | OMIM:607236 | Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa,and pallidal degeneration | . | | | 55 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PANK2 CL E G H | 80025 | 15894 | OMIM:234200 | Neurodegeneration with brain iron accumulation 1 | . | | | 55 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PARK7 CL E G H | 11315 | 16369 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 23 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PDGFB CL E G H | 5155 | 8800 | OMIM:615483 | Basal ganglia calcification, idiopathic, 5 | . | | | 9 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PDGFRB CL E G H | 5159 | 8804 | OMIM:615007 | Basal ganglia calcification, idiopathic, 4 | HP:0040283 - Occasional | | | 28 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | PDGFRB CL E G H | 5159 | 8804 | OMIM:616592 | Kosaki overgrowth syndrome | . | | | 28 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PINK1 CL E G H | 65018 | 14581 | OMIM:605909 | Parkinson disease 6, autosomal recessive early-onset | . | | | 55 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PINK1 CL E G H | 65018 | 14581 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 55 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PLA2G6 CL E G H | 8398 | 9039 | ORPHA:199351 | Adult-onset dystonia-parkinsonism | | | | 133 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | PLA2G6 CL E G H | 8398 | 9039 | ORPHA:35069 | Infantile neuroaxonal dystrophy | HP:0040281 - Very frequent | | | 133 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PLA2G6 CL E G H | 8398 | 9039 | OMIM:612953 | Parkinson disease 14, autosomal recessive | | | | 133 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PLAU CL E G H | 5328 | 9052 | OMIM:104300 | Alzheimer disease | . | | | 50 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | PLEKHG4 CL E G H | 25894 | 24501 | ORPHA:98765 | Spinocerebellar ataxia type 4 | HP:0040282 - Frequent | | | 4 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | PLP1 CL E G H | 5354 | 9086 | OMIM:312080 | Pelizaeus-Merzbacher disease | | | | 60 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | PMPCA CL E G H | 23203 | 18667 | ORPHA:1170 | Autosomal recessive cerebelloparenchymal disorder type 3 | | | | 7 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PNPLA6 CL E G H | 10908 | 16268 | ORPHA:1173 | Cerebellar ataxia-hypogonadism syndrome | HP:0040283 - Occasional | | | 103 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PODXL CL E G H | 5420 | 9171 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 6 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | POLG CL E G H | 5428 | 9179 | OMIM:203700 | Mitochondrial DNA depletion syndrome 4A (Alpers type) | . | | | 464 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | POLG CL E G H | 5428 | 9179 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040284 - Very rare | | | 464 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | POLG CL E G H | 5428 | 9179 | OMIM:607459 | Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | | | | 464 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PPP2R2B CL E G H | 5521 | 9305 | OMIM:604326 | Spinocerebellar ataxia 12 | . | | | 5 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PPP2R2B CL E G H | 5521 | 9305 | ORPHA:98762 | Spinocerebellar ataxia type 12 | HP:0040283 - Occasional | | | 5 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | PPT1 CL E G H | 5538 | 9325 | OMIM:256730 | Ceroid lipofuscinosis, neuronal, 1 | . | | | 172 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRDM8 CL E G H | 56978 | 13993 | OMIM:616640 | Epilepsy, progressive myoclonic, 10 | . | | | 1 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRDX1 CL E G H | 5052 | 9352 | OMIM:277400 | Methylmalonic aciduria and homocystinuria, Cblc type | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRICKLE1 CL E G H | 144165 | 17019 | ORPHA:308 | Progressive myoclonic epilepsy type 1 | HP:0040283 - Occasional | | | 133 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | PRKAR1B CL E G H | 5575 | 9390 | ORPHA:412066 | PRKAR1B-related neurodegenerative dementia with intermediate filaments | HP:0040281 - Very frequent | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRKAR1B CL E G H | 5575 | 9390 | ORPHA:412066 | PRKAR1B-related neurodegenerative dementia with intermediate filaments | HP:0040280 - Obligate | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRKN CL E G H | 5071 | 8607 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 138 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRNP CL E G H | 5621 | 9449 | OMIM:123400 | Creutzfeldt-Jakob disease | . | | | 69 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRNP CL E G H | 5621 | 9449 | OMIM:600072 | Fatal familial insomnia | . | | | 69 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRNP CL E G H | 5621 | 9449 | OMIM:137440 | Gerstmann-Straussler disease | . | HP:0003584 - Late onset | | 69 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRNP CL E G H | 5621 | 9449 | ORPHA:356 | Gerstmann-Straussler-Scheinker syndrome | HP:0040282 - Frequent | | | 69 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRNP CL E G H | 5621 | 9449 | OMIM:603218 | Huntington disease-like 1 | . | | | 69 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRNP CL E G H | 5621 | 9449 | ORPHA:157941 | Huntington disease-like 1 | HP:0040282 - Frequent | | | 69 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRNP CL E G H | 5621 | 9449 | ORPHA:282166 | Inherited Creutzfeldt-Jakob disease | HP:0040282 - Frequent | | | 69 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PRNP CL E G H | 5621 | 9449 | OMIM:606688 | Spongiform encephalopathy with neuropsychiatric features | . | | | 69 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:206436 | Infantile Krabbe disease | HP:0040282 - Frequent | | | 81 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:206436 | Infantile Krabbe disease | HP:0040281 - Very frequent | | | 81 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | PSAP CL E G H | 5660 | 9498 | OMIM:611722 | KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY | | | | 81 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | | | | 81 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040282 - Frequent | | | 81 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | PSAP CL E G H | 5660 | 9498 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | | | | 81 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN1 CL E G H | 5663 | 9508 | OMIM:607822 | Alzheimer disease 3 | . | | | 241 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | | | | 241 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 241 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN1 CL E G H | 5663 | 9508 | OMIM:600274 | Frontotemporal dementia | | | | 241 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN1 CL E G H | 5663 | 9508 | OMIM:172700 | Pick disease of brain | | | | 241 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:100070 | Progressive non-fluent aphasia | | | | 241 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:100069 | Semantic dementia | HP:0040282 - Frequent | | | 241 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN2 CL E G H | 5664 | 9509 | OMIM:606889 | Alzheimer disease 4 | | | | 59 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN2 CL E G H | 5664 | 9509 | OMIM:613697 | Cardiomyopathy, dilated, 1V | | | | 59 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | PSEN2 CL E G H | 5664 | 9509 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 59 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | PTS CL E G H | 5805 | 9689 | OMIM:261640 | Hyperphenylalaninemia, BH4-deficient, A | . | | | 19 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | QDPR CL E G H | 5860 | 9752 | OMIM:261630 | Hyperphenylalaninemia, bh4-deficient, C | . | | | 43 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | RAB27A CL E G H | 5873 | 9766 | OMIM:607624 | Griscelli syndrome, type 2 | HP:0040283 - Occasional | | | 67 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | RAB39B CL E G H | 116442 | 16499 | OMIM:311510 | Waisman syndrome | HP:0040283 - Occasional | | | 34 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | RBM28 CL E G H | 55131 | 21863 | OMIM:612079 | Alopecia, neurologic defects, and endocrinopathy syndrome | . | | | 1 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | RBM28 CL E G H | 55131 | 21863 | ORPHA:157954 | ANE syndrome | HP:0040282 - Frequent | | | 1 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | RNASEH1 CL E G H | 246243 | 18466 | ORPHA:329336 | Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy | HP:0040283 - Occasional | | | 3 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | RNF216 CL E G H | 54476 | 21698 | OMIM:212840 | Cerebellar ataxia and hypogonadotropic hypogonadism | . | | | 10 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | RNF216 CL E G H | 54476 | 21698 | ORPHA:1173 | Cerebellar ataxia-hypogonadism syndrome | HP:0040283 - Occasional | | | 10 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | RNU4ATAC CL E G H | 100151683 | 34016 | OMIM:210710 | Microcephalic osteodysplastic primordial dwarfism, type I | | | | 15 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ROGDI CL E G H | 79641 | 29478 | ORPHA:1946 | Amelocerebrohypohidrotic syndrome | HP:0040281 - Very frequent | | | 57 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ROGDI CL E G H | 79641 | 29478 | OMIM:226750 | Kohlschutter-Tonz syndrome | . | | | 57 | | |
HP:0001268 | HP:0002361 | Psychomotor deterioration | 1 | RRM2B CL E G H | 50484 | 17296 | ORPHA:329336 | Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy | HP:0040283 - Occasional | | | 125 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | RRM2B CL E G H | 50484 | 17296 | OMIM:612075 | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) | . | | | 125 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | RRM2B CL E G H | 50484 | 17296 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040284 - Very rare | | | 125 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | RTN4R CL E G H | 65078 | 18601 | OMIM:181500 | SCHIZOPHRENIA | . | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SCARB2 CL E G H | 950 | 1665 | ORPHA:308 | Progressive myoclonic epilepsy type 1 | HP:0040283 - Occasional | | | 77 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SDHA CL E G H | 6389 | 10680 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040284 - Very rare | | | 304 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SDHA CL E G H | 6389 | 10680 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | | | | 304 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | SDHA CL E G H | 6389 | 10680 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040282 - Frequent | | | 304 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | SDHAF1 CL E G H | 644096 | 33867 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040282 - Frequent | | | 16 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SDHAF1 CL E G H | 644096 | 33867 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | | | | 16 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SDHAF1 CL E G H | 644096 | 33867 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040284 - Very rare | | | 16 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SDHB CL E G H | 6390 | 10681 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | | | | 237 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SDHB CL E G H | 6390 | 10681 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040284 - Very rare | | | 237 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | SDHB CL E G H | 6390 | 10681 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040282 - Frequent | | | 237 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | SDHD CL E G H | 6392 | 10683 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040282 - Frequent | | | 129 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SDHD CL E G H | 6392 | 10683 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | | | | 129 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SDHD CL E G H | 6392 | 10683 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040284 - Very rare | | | 129 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SERPINI1 CL E G H | 5274 | 8943 | OMIM:604218 | Encephalopathy, familial, with neuroserpin inclusion bodies | . | | | 28 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SLC13A3 CL E G H | 64849 | 14430 | OMIM:618384 | Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate | | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SLC13A5 CL E G H | 284111 | 23089 | ORPHA:1946 | Amelocerebrohypohidrotic syndrome | HP:0040281 - Very frequent | | | 73 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SLC1A3 CL E G H | 6507 | 10941 | ORPHA:2131 | Alternating hemiplegia of childhood | HP:0040283 - Occasional | | | 63 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SLC39A14 CL E G H | 23516 | 20858 | OMIM:617013 | Hypermanganesemia with dystonia 2 | | | | 5 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SNCA CL E G H | 6622 | 11138 | OMIM:127750 | Dementia, lewy body | . | | | 65 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SNCA CL E G H | 6622 | 11138 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040284 - Very rare | | | 65 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SNCA CL E G H | 6622 | 11138 | OMIM:168601 | Parkinson disease 1, autosomal dominant | . | | | 65 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SNCA CL E G H | 6622 | 11138 | OMIM:605543 | Parkinson disease 4 | . | | | 65 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SNCA CL E G H | 6622 | 11138 | ORPHA:171695 | Parkinsonian-pyramidal syndrome | HP:0040283 - Occasional | | | 65 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SNCA CL E G H | 6622 | 11138 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 65 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SNCAIP CL E G H | 9627 | 11139 | OMIM:168600 | Parkinson disease, late-onset | . | | | 35 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SNCB CL E G H | 6620 | 11140 | OMIM:127750 | Dementia, lewy body | . | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SORL1 CL E G H | 6653 | 11185 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 3 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SPAST CL E G H | 6683 | 11233 | OMIM:182601 | Spastic paraplegia 4, autosomal dominant | . | | | 208 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SPG11 CL E G H | 80208 | 11226 | ORPHA:2822 | Autosomal recessive spastic paraplegia type 11 | HP:0040283 - Occasional | | | 287 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SPG21 CL E G H | 51324 | 20373 | ORPHA:101001 | Autosomal recessive spastic paraplegia type 21 | HP:0040281 - Very frequent | | | 28 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SPG21 CL E G H | 51324 | 20373 | OMIM:248900 | Mast syndrome | . | | | 28 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SQSTM1 CL E G H | 8878 | 11280 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | | | | 62 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SQSTM1 CL E G H | 8878 | 11280 | OMIM:616437 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 | | | | 62 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SQSTM1 CL E G H | 8878 | 11280 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 62 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | STARD7 CL E G H | 56910 | 18063 | OMIM:607876 | Epilepsy, familial adult myoclonic, 2 | | | | | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SUMF1 CL E G H | 285362 | 20376 | ORPHA:585 | Multiple sulfatase deficiency | | | | 80 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SUMF1 CL E G H | 285362 | 20376 | OMIM:272200 | Multiple sulfatase deficiency | | | | 80 | | |
HP:0001268 | HP:0007086 | Social and occupational deterioration | 1 | SYN2 CL E G H | 6854 | 11495 | OMIM:181500 | SCHIZOPHRENIA | . | | | 3 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | SYNJ1 CL E G H | 8867 | 11503 | OMIM:617389 | Epileptic encephalopathy, early infantile, 53 | . | | | 9 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | SYNJ1 CL E G H | 8867 | 11503 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 9 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TARDBP CL E G H | 23435 | 11571 | OMIM:612069 | Amyotrophic lateral sclerosis 10 with or without frontotemporal dementia | | | | 65 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TARDBP CL E G H | 23435 | 11571 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 65 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TBK1 CL E G H | 29110 | 11584 | OMIM:616439 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 | | | | 20 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TBK1 CL E G H | 29110 | 11584 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 20 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TBP CL E G H | 6908 | 11588 | OMIM:168600 | Parkinson disease, late-onset | . | | | 7 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TBP CL E G H | 6908 | 11588 | OMIM:607136 | Spinocerebellar ataxia 17 | | | | 7 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TIA1 CL E G H | 7072 | 11802 | OMIM:619133 | AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS26 | | | | 5 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TIMM8A CL E G H | 1678 | 11817 | ORPHA:52368 | Mohr-Tranebjaerg syndrome | HP:0040283 - Occasional | | | 15 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | TIMMDC1 CL E G H | 51300 | 1321 | OMIM:618251 | MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31 | | | | 1 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | TINF2 CL E G H | 26277 | 11824 | OMIM:268130 | Revesz syndrome | . | | | 60 | | |
HP:0001268 | HP:0002333 | Motor deterioration | 1 | TK2 CL E G H | 7084 | 11831 | ORPHA:254875 | Mitochondrial DNA depletion syndrome, myopathic form | HP:0040281 - Very frequent | | | 103 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TMEM106B CL E G H | 54664 | 22407 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TMEM106B CL E G H | 54664 | 22407 | ORPHA:100070 | Progressive non-fluent aphasia | | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TMEM106B CL E G H | 54664 | 22407 | ORPHA:100069 | Semantic dementia | HP:0040282 - Frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TOMM40 CL E G H | 10452 | 18001 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TP53 CL E G H | 7157 | 11998 | ORPHA:96253 | Cushing disease | | | | 911 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TREM2 CL E G H | 54209 | 17761 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | | | | 31 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TREM2 CL E G H | 54209 | 17761 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040281 - Very frequent | | | 31 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TREM2 CL E G H | 54209 | 17761 | ORPHA:2770 | Nasu-Hakola disease | | | | 31 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TREM2 CL E G H | 54209 | 17761 | OMIM:618193 | POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL2 | | | | 31 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TREM2 CL E G H | 54209 | 17761 | ORPHA:100070 | Progressive non-fluent aphasia | | | | 31 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TREM2 CL E G H | 54209 | 17761 | ORPHA:100069 | Semantic dementia | HP:0040282 - Frequent | | | 31 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | TREX1 CL E G H | 11277 | 12269 | ORPHA:247691 | Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations | HP:0040283 - Occasional | | | 56 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TREX1 CL E G H | 11277 | 12269 | OMIM:192315 | Vasculopathy, retinal, with cerebral leukodystrophy | . | | | 56 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNC CL E G H | 4511 | 7477 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNE CL E G H | 4556 | 7479 | ORPHA:2596 | Myopathy and diabetes mellitus | HP:0040284 - Very rare | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNF CL E G H | 4558 | 7481 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNF CL E G H | 4558 | 7481 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNH CL E G H | 4564 | 7487 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNK CL E G H | 4566 | 7489 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNL1 CL E G H | 4567 | 7490 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNQ CL E G H | 4572 | 7495 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNQ CL E G H | 4572 | 7495 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNS1 CL E G H | 4574 | 7497 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNS2 CL E G H | 4575 | 7498 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNS2 CL E G H | 4575 | 7498 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNT CL E G H | 4576 | 7499 | OMIM:168600 | Parkinson disease, late-onset | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNV CL E G H | 4577 | 7500 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNW CL E G H | 4578 | 7501 | ORPHA:550 | MELAS | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRNW CL E G H | 4578 | 7501 | OMIM:540000 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | . | | | | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TRPM7 CL E G H | 54822 | 17994 | OMIM:105500 | Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 | . | | | 2 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TTR CL E G H | 7276 | 12405 | OMIM:105210 | Amyloidosis, hereditary, transthyretin-related | . | | | 107 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TUBA4A CL E G H | 7277 | 12407 | OMIM:616208 | Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia | | | | 6 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TUBB4A CL E G H | 10382 | 20774 | ORPHA:98805 | Primary dystonia, DYT4 type | HP:0040283 - Occasional | | | 66 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TWNK CL E G H | 56652 | 1160 | OMIM:609286 | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 | . | HP:0003584 - Late onset | | 113 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TWNK CL E G H | 56652 | 1160 | OMIM:607459 | Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | | | | 113 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TYMP CL E G H | 1890 | 3148 | ORPHA:298 | Mitochondrial neurogastrointestinal encephalomyopathy | HP:0040284 - Very rare | | | 138 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TYROBP CL E G H | 7305 | 12449 | ORPHA:2770 | Nasu-Hakola disease | | | | 22 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | TYROBP CL E G H | 7305 | 12449 | OMIM:221770 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy | | | | 22 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | UBQLN2 CL E G H | 29978 | 12509 | OMIM:300857 | Amyotrophic lateral sclerosis 15 with or without frontotemporal dementia | | | | 20 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | UCHL1 CL E G H | 7345 | 12513 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 21 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | USP48 CL E G H | 84196 | 18533 | ORPHA:96253 | Cushing disease | | | | 1 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | USP8 CL E G H | 9101 | 12631 | ORPHA:96253 | Cushing disease | | | | 7 | | |
HP:0001268 | HP:0002344 | Progressive neurologic deterioration | 1 | VCP CL E G H | 7415 | 12666 | ORPHA:329478 | Adult-onset distal myopathy due to VCP mutation | HP:0040282 - Frequent | | | 63 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VCP CL E G H | 7415 | 12666 | ORPHA:329478 | Adult-onset distal myopathy due to VCP mutation | HP:0040282 - Frequent | | | 63 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VCP CL E G H | 7415 | 12666 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | | | | 63 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VCP CL E G H | 7415 | 12666 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | | | | 63 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VCP CL E G H | 7415 | 12666 | OMIM:167320 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1 | . | | | 63 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VCP CL E G H | 7415 | 12666 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | | | | 63 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VCP CL E G H | 7415 | 12666 | ORPHA:100070 | Progressive non-fluent aphasia | | | | 63 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VPS13A CL E G H | 23230 | 1908 | OMIM:200150 | CHOREOACANTHOCYTOSIS | HP:0040283 - Occasional | | | 130 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VPS13C CL E G H | 54832 | 23594 | OMIM:616840 | Parkinson disease 23, autosomal recessive early-onset | . | | | 8 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VPS13C CL E G H | 54832 | 23594 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040283 - Occasional | | | 8 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | VPS35 CL E G H | 55737 | 13487 | ORPHA:411602 | Hereditary late-onset Parkinson disease | HP:0040284 - Very rare | | | 37 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | WDR45 CL E G H | 11152 | 28912 | ORPHA:329284 | Beta-propeller protein-associated neurodegeneration | HP:0040282 - Frequent | | | 51 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | WDR45 CL E G H | 11152 | 28912 | OMIM:300894 | Neurodegeneration with brain iron accumulation 5 | . | | | 51 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | WFS1 CL E G H | 7466 | 12762 | ORPHA:3463 | Wolfram syndrome | HP:0040283 - Occasional | | | 389 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | WFS1 CL E G H | 7466 | 12762 | ORPHA:411590 | Wolfram-like syndrome | HP:0040281 - Very frequent | | | 389 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | XPR1 CL E G H | 9213 | 12827 | OMIM:616413 | Basal ganglia calcification, idiopathic, 6 | . | | | 4 | | |
HP:0001268 | HP:0000726 | Dementia | 1 | ZFYVE26 CL E G H | 23503 | 20761 | ORPHA:100996 | Autosomal recessive spastic paraplegia type 15 | HP:0040283 - Occasional | | | 189 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | ABCA7 CL E G H | 10347 | 37 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 3 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | APP CL E G H | 351 | 620 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 74 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | ARSA CL E G H | 410 | 713 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040283 - Occasional | | | 253 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | ARSA CL E G H | 410 | 713 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | HP:0040283 - Occasional | | | 253 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | BSCL2 CL E G H | 26580 | 15832 | ORPHA:363400 | Severe neurodegenerative syndrome with lipodystrophy | HP:0040281 - Very frequent | | | 105 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | C9ORF72 CL E G H | 203228 | 28337 | OMIM:105550 | Amyotrophic lateral sclerosis and/or frontotemporal dementia 1 | . | | | 56 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 56 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | HP:0040281 - Very frequent | | | 56 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | C9ORF72 CL E G H | 203228 | 28337 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 56 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | CCNF CL E G H | 899 | 1591 | OMIM:619141 | FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 5; FTDALS5 | | | | | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | CHCHD10 CL E G H | 400916 | 15559 | OMIM:615911 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 | . | | | 11 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | CHCHD10 CL E G H | 400916 | 15559 | OMIM:615911 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 2 | . | | | 11 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | CHCHD10 CL E G H | 400916 | 15559 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | HP:0040281 - Very frequent | | | 11 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | CHMP2B CL E G H | 25978 | 24537 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 42 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | CHMP2B CL E G H | 25978 | 24537 | OMIM:600795 | Frontotemporal dementia and/or amytrophic lateral sclerosis 7 | . | | | 42 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | CHMP2B CL E G H | 25978 | 24537 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 42 | | |
HP:0001268 | HP:0007064 | Progressive language deterioration | 2 | CNTNAP2 CL E G H | 26047 | 13830 | ORPHA:163681 | CNTNAP2-related developmental and epileptic encephalopathy | | | | 518 | | |
HP:0001268 | HP:0007064 | Progressive language deterioration | 2 | CNTNAP2 CL E G H | 26047 | 13830 | OMIM:610042 | Pitt-Hopkins-Like syndrome 1 | . | | | 518 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | CSF1R CL E G H | 1436 | 2433 | OMIM:221820 | Leukoencephalopathy, diffuse hereditary, with spheroids | . | | | 149 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | CYLD CL E G H | 1540 | 2584 | OMIM:619132 | FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 8; FTDALS8 | | | | 126 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | CYP27A1 CL E G H | 1593 | 2605 | ORPHA:909 | Cerebrotendinous xanthomatosis | HP:0040282 - Frequent | | | 114 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | DCTN1 CL E G H | 1639 | 2711 | OMIM:168605 | Perry syndrome | . | | | 86 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | DNAJC6 CL E G H | 9829 | 15469 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 6 | | |
HP:0001268 | HP:0007123 | Subcortical dementia | 2 | FTL CL E G H | 2512 | 3999 | OMIM:606159 | Neurodegeneration with brain iron accumulation 3 | . | | | 33 | | |
HP:0001268 | HP:0007123 | Subcortical dementia | 2 | FTL CL E G H | 2512 | 3999 | ORPHA:157846 | Neuroferritinopathy | HP:0040284 - Very rare | | | 33 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | FTL CL E G H | 2512 | 3999 | ORPHA:157846 | Neuroferritinopathy | HP:0040284 - Very rare | | | 33 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | FUS CL E G H | 2521 | 4010 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | HP:0040281 - Very frequent | | | 105 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | GLB1 CL E G H | 2720 | 4298 | OMIM:230600 | Gm1-gangliosidosis, type II | . | | | 120 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | GRN CL E G H | 2896 | 4601 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 126 | | |
HP:0001268 | HP:0007064 | Progressive language deterioration | 2 | GRN CL E G H | 2896 | 4601 | OMIM:607485 | Frontotemporal lobar degeneration with TDP43 inclusions | . | | | 126 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | GRN CL E G H | 2896 | 4601 | OMIM:607485 | Frontotemporal lobar degeneration with TDP43 inclusions | . | | | 126 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | GRN CL E G H | 2896 | 4601 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 126 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | HEXB CL E G H | 3074 | 4879 | OMIM:268800 | Sandhoff disease | . | | | 80 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | HNRNPA1 CL E G H | 3178 | 5031 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | HP:0040282 - Frequent | | | 31 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | HNRNPA2B1 CL E G H | 3181 | 5033 | OMIM:615422 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 2 | . | | | 5 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | HNRNPA2B1 CL E G H | 3181 | 5033 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | HP:0040282 - Frequent | | | 5 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | HTRA2 CL E G H | 27429 | 14348 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 39 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | KCTD7 CL E G H | 154881 | 21957 | ORPHA:263516 | Progressive myoclonic epilepsy type 3 | HP:0040282 - Frequent | | | 106 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | LRRK2 CL E G H | 120892 | 18618 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 221 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | MAPT CL E G H | 4137 | 6893 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 140 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | MAPT CL E G H | 4137 | 6893 | OMIM:600274 | Frontotemporal dementia | . | | | 140 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | MAPT CL E G H | 4137 | 6893 | OMIM:600274 | Frontotemporal dementia | . | | | 140 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | MAPT CL E G H | 4137 | 6893 | OMIM:172700 | Pick disease of brain | . | | | 140 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | MAPT CL E G H | 4137 | 6893 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 140 | | |
HP:0001268 | HP:0002439 | Frontolimbic dementia | 2 | MAPT CL E G H | 4137 | 6893 | OMIM:601104 | Supranuclear palsy, progressive, 1 | . | | | 140 | | |
HP:0001268 | HP:0007123 | Subcortical dementia | 2 | NOTCH3 CL E G H | 4854 | 7883 | OMIM:125310 | Cerebral arteriopathy, autosomal dominant, with subcortical infarctsand leukoencephalopathy | . | | | 144 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | PARK7 CL E G H | 11315 | 16369 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 23 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | PINK1 CL E G H | 65018 | 14581 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 55 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | PLA2G6 CL E G H | 8398 | 9039 | ORPHA:199351 | Adult-onset dystonia-parkinsonism | HP:0040282 - Frequent | | | 133 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | PLA2G6 CL E G H | 8398 | 9039 | OMIM:612953 | Parkinson disease 14, autosomal recessive | . | | | 133 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | PMPCA CL E G H | 23203 | 18667 | ORPHA:1170 | Autosomal recessive cerebelloparenchymal disorder type 3 | HP:0040282 - Frequent | | | 7 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | PODXL CL E G H | 5420 | 9171 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 6 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | PRKAR1B CL E G H | 5575 | 9390 | ORPHA:412066 | PRKAR1B-related neurodegenerative dementia with intermediate filaments | HP:0040281 - Very frequent | | | 2 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | PRKN CL E G H | 5071 | 8607 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 138 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | PSAP CL E G H | 5660 | 9498 | ORPHA:309271 | Metachromatic leukodystrophy, adult form | HP:0040283 - Occasional | | | 81 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | PSAP CL E G H | 5660 | 9498 | ORPHA:309263 | Metachromatic leukodystrophy, juvenile form | HP:0040283 - Occasional | | | 81 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 241 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 241 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | PSEN1 CL E G H | 5663 | 9508 | OMIM:600274 | Frontotemporal dementia | . | | | 241 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | PSEN1 CL E G H | 5663 | 9508 | OMIM:600274 | Frontotemporal dementia | . | | | 241 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | PSEN1 CL E G H | 5663 | 9508 | OMIM:172700 | Pick disease of brain | . | | | 241 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 241 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | PSEN2 CL E G H | 5664 | 9509 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 59 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | SDHA CL E G H | 6389 | 10680 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040282 - Frequent | | | 304 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | SDHAF1 CL E G H | 644096 | 33867 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040282 - Frequent | | | 16 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | SDHB CL E G H | 6390 | 10681 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040282 - Frequent | | | 237 | | |
HP:0001268 | HP:0007272 | Progressive psychomotor deterioration | 2 | SDHD CL E G H | 6392 | 10683 | ORPHA:3208 | Isolated succinate-CoQ reductase deficiency | HP:0040282 - Frequent | | | 129 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | SNCA CL E G H | 6622 | 11138 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 65 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | SORL1 CL E G H | 6653 | 11185 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 3 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | SQSTM1 CL E G H | 8878 | 11280 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 62 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | SQSTM1 CL E G H | 8878 | 11280 | OMIM:616437 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 3 | . | | | 62 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | SQSTM1 CL E G H | 8878 | 11280 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | HP:0040281 - Very frequent | | | 62 | | |
HP:0001268 | HP:0007307 | Rapid neurologic deterioration | 2 | SUMF1 CL E G H | 285362 | 20376 | OMIM:272200 | Multiple sulfatase deficiency | . | | | 80 | | |
HP:0001268 | HP:0007307 | Rapid neurologic deterioration | 2 | SUMF1 CL E G H | 285362 | 20376 | ORPHA:585 | Multiple sulfatase deficiency | HP:0040281 - Very frequent | | | 80 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | SYNJ1 CL E G H | 8867 | 11503 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 9 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TARDBP CL E G H | 23435 | 11571 | OMIM:612069 | Amyotrophic lateral sclerosis 10 with or without frontotemporal dementia | . | | | 65 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TARDBP CL E G H | 23435 | 11571 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | HP:0040281 - Very frequent | | | 65 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TBK1 CL E G H | 29110 | 11584 | OMIM:616439 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 | . | | | 20 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TBK1 CL E G H | 29110 | 11584 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | HP:0040281 - Very frequent | | | 20 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | TBP CL E G H | 6908 | 11588 | OMIM:607136 | Spinocerebellar ataxia 17 | . | | | 7 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TIA1 CL E G H | 7072 | 11802 | OMIM:619133 | AMYOTROPHIC LATERAL SCLEROSIS 26 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS26 | | | | 5 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TMEM106B CL E G H | 54664 | 22407 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TMEM106B CL E G H | 54664 | 22407 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TOMM40 CL E G H | 10452 | 18001 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TREM2 CL E G H | 54209 | 17761 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 31 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TREM2 CL E G H | 54209 | 17761 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | | | | 31 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | TREM2 CL E G H | 54209 | 17761 | ORPHA:2770 | Nasu-Hakola disease | HP:0040281 - Very frequent | | | 31 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TREM2 CL E G H | 54209 | 17761 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 31 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | TUBA4A CL E G H | 7277 | 12407 | OMIM:616208 | Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia | HP:0040283 - Occasional | | | 6 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | TYROBP CL E G H | 7305 | 12449 | ORPHA:2770 | Nasu-Hakola disease | HP:0040281 - Very frequent | | | 22 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | TYROBP CL E G H | 7305 | 12449 | OMIM:221770 | Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy | . | | | 22 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | UBQLN2 CL E G H | 29978 | 12509 | OMIM:300857 | Amyotrophic lateral sclerosis 15 with or without frontotemporal dementia | . | | | 20 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | UCHL1 CL E G H | 7345 | 12513 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 21 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | VCP CL E G H | 7415 | 12666 | ORPHA:275864 | Behavioral variant of frontotemporal dementia | HP:0040281 - Very frequent | | | 63 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | VCP CL E G H | 7415 | 12666 | ORPHA:275872 | Frontotemporal dementia with motor neuron disease | HP:0040281 - Very frequent | | | 63 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | VCP CL E G H | 7415 | 12666 | OMIM:167320 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1 | . | | | 63 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | VCP CL E G H | 7415 | 12666 | ORPHA:52430 | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | HP:0040282 - Frequent | | | 63 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | VCP CL E G H | 7415 | 12666 | ORPHA:100070 | Progressive non-fluent aphasia | HP:0040281 - Very frequent | | | 63 | | |
HP:0001268 | HP:0000727 | Frontal lobe dementia | 2 | VPS13C CL E G H | 54832 | 23594 | ORPHA:2828 | Young-onset Parkinson disease | HP:0040284 - Very rare | | | 8 | | |
HP:0001268 | HP:0002145 | Frontotemporal dementia | 2 | ZFYVE26 CL E G H | 23503 | 20761 | ORPHA:100996 | Autosomal recessive spastic paraplegia type 15 | HP:0040283 - Occasional | | | 189 | | |
HP:0001268 | HP:0030219 | Semantic dementia | 3 | ABCA7 CL E G H | 10347 | 37 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040283 - Occasional | | | 3 | | |
HP:0001268 | HP:0030219 | Semantic dementia | 3 | APP CL E G H | 351 | 620 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040283 - Occasional | | | 74 | | |
HP:0001268 | HP:0030219 | Semantic dementia | 3 | PSEN1 CL E G H | 5663 | 9508 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040283 - Occasional | | | 241 | | |
HP:0001268 | HP:0030219 | Semantic dementia | 3 | PSEN2 CL E G H | 5664 | 9509 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040283 - Occasional | | | 59 | | |
HP:0001268 | HP:0030219 | Semantic dementia | 3 | SORL1 CL E G H | 6653 | 11185 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040283 - Occasional | | | 3 | | |
HP:0001268 | HP:0030219 | Semantic dementia | 3 | TOMM40 CL E G H | 10452 | 18001 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040283 - Occasional | | | | | |
HP:0001268 | HP:0030219 | Semantic dementia | 3 | TREM2 CL E G H | 54209 | 17761 | ORPHA:1020 | Early-onset autosomal dominant Alzheimer disease | HP:0040283 - Occasional | | | 31 | | |